Curriculum Vitae

PROF. DR. HASNIZA BINTI ZAMAN HURI

Professor
  • Department of Clinical Pharmacy and Pharmacy Practice
    Faculty of Pharmacy
  • hasnizazh
  • +603-79676659

BIOGRAPHY

Professor Dr Hasniza Zaman Huri, currently the Deputy Vice Chancellor of Academic and International, is an accomplished academic pharmacist and the founding Dean of the Faculty of Pharmacy at Universiti Malaya. Under her leadership, the faculty has achieved numerous accolades, including being a founding member of the Global Alliance for the Development of Pharmaceutical Science (GADPS), an alliance to spearhead the excellent teaching & learning and research of pharmacy/pharmaceutical sciences school around the globe, the top KPI achiever for academic centre in 2023, top faculty for graduate employability and for the first time, top 100 (#72) for Pharmacy subject ranking in the QS World University Rankings 2024. Professor Dr Hasniza was also appointed as the General Assembly Representative for GADPS.  As a leading clinical scientist in clinical pharmacy, precision medicine and targeted therapy, she was honoured with the World Class Professor Programme by the Indonesian Government in 2022, among 78 professors globally. Professor Dr Hasniza's research expertise focuses on targeted therapy, drug utilisation and precision medicine, especially in metabolic diseases. She has been invited by various countries such as the United Kingdom, Uzbekistan, Turkey, China, India, Taiwan, and Indonesia as a Keynote or Plenary Speaker at conferences. She has published over 100 publications indexed in the Web of Science (WoS). Professor Dr Hasniza is also an expert in the clinical trial industry and is recognized for her exemplary leadership. She was the Manager and later Director of the Clinical Investigation Centre (CIC) at the University Malaya Medical Centre (UMMC). During her tenure, CIC UMMC gained a world-class reputation, winning multiple distinctions, including being the first Strategic Alliance Site for Parexel Inc. in Malaysia, Pfizer’s INSPIRE (Investigator Networks, Site Partnerships and Infrastructure for Research Excellence) Site in Malaysia, Best Clinical Trial Service Provider in Asia, Top-10 IQVIA Prime Sites in the world and many more. She was awarded Best Academic Administrator for Non-Academic Centre in 2015 by Universiti Malaya and recently, in 2024, was awarded the MPS Outstanding Leadership Award by the Malaysian Pharmacists Society (MPS), an excellence award due to her outstanding performance and exceptional achievement in pharmacy practice in Malaysia. She is also the Honorary Visiting Consultant at CIC and a member of the Drug Control Authority (DCA) Ministry of Health, Malaysia.

 

 

ACADEMIC QUALIFICATION

  • PhD(UM), (PHILOSOPHY)
    Universiti Kebangsaan Malaysia (ukm)
  • MPharm(Clinical)(UKM), (FARMASI KLINIKAL)
    Universiti Kebangsaan Malaysia (ukm)
  • BPHARM (Hons)(UM), (FARMASI)
    Universiti Malaya (um)

ADMINISTRATIVE DUTIES

  • Deputy Vice-chancellor (academic & Internationalisation)
    20 Jan 2025 - present (Deputy Vice-chancellor (academic and International) Office, Deputy Vice-chancellor (academic and International))
  • Dean
    01 Jan 2025 - 19 Jan 2025 (Faculty of Pharmacy Dean's Office, Faculty of Pharmacy)
  • Academic advisor
    12 Sep 2011 - present (Department of Pharmacy, Faculty of Medicine)
  • Secretary of CIC Advisory Board Committee
    01 Oct 2012 - present (University Malaya)
  • Postgraduate (High Degree) Committee, Department of Pharmacy, Faculty of Medicine, University of Malaya.
    02 Jan 2013 - present (University Malaya)
  • Coordinator of Students Achievement Award
    05 Aug 2011 - present (Department of Pharmacy, Faculty of Medicine)
  • Chairman of Technical Assessment Committee Members for Purchasing of Real Time PCR
    16 Oct 2013 - present (University Malaya)
  • Head of Unit - Clinical and Practice Pharmacy
    10 Jul 2015 - present (Department of Pharmacy, Faculty of Medicine)
  • Director and Head - Clinical Investigation Centre (CIC), University Malaya Medical Centre
    15 Aug 2015 - present (University Malaya)
  • Coordinator of Introduction to Clinical Pharmacy module
    22 Jul 2011 - present (Department of Pharmacy, Faculty of Medicine)
  • Faculty Appeal Committee Member for Semester Program
    18 Nov 2014 - present (Department of Pharmacy, Faculty of Medicine)
  • Coordinator of Integrated Pharmacotherapy module
    22 Jul 2011 - present (Department of Pharmacy, Faculty of Medicine)
  • Coordinator of Health Supplements module
    22 Jul 2011 - present (Department of Pharmacy, Faculty of Medicine)
  • Level Coordinator (Professional year)
    03 Sep 2012 - present (Department of Pharmacy, Faculty of Medicine)
  • Dean
    01 Jan 2022 - 31 Dec 2024 (Faculty of Pharmacy Dean's Office, Faculty of Pharmacy)
  • Investigation Team Pool
    02 Jan 2020 - 02 Jan 2022 (University Malaya)
  • Dean
    01 Sep 2021 - 31 Dec 2021 (Faculty of Pharmacy Dean's Office, Faculty of Pharmacy)
  • Dean
    01 Sep 2019 - 31 Aug 2021 (Faculty of Pharmacy Dean's Office, Faculty of Pharmacy)
  • Dean, Faculty of Pharmacy
    01 Sep 2019 - 31 Aug 2021 (University Malaya)
  • Committee Member for Jawatankuasa Pengurusan Strategik UMMC
    16 Oct 2017 - 31 Dec 2020 (University Malaya)
  • Secretary of Risk Management Committee of Research (UMMC)
    16 Oct 2017 - 31 Dec 2020 (University Malaya)
  • Deputy Chairman of Human Research Protection Program (HRPP)
    25 Aug 2017 - 31 Dec 2020 (University Malaya)
  • Head of Thrust 2 (Research) for UMMC Strategic Planning Program
    16 Oct 2017 - 31 Dec 2020 (University Malaya)
  • Head of Department
    01 Aug 2019 - 11 Aug 2020 (University Malaya)
  • Head
    01 Jan 2018 - 31 Dec 2019 (Clinical Research Centre, Faculty of Medicine)
  • Head of Department
    15 Aug 2015 - 30 Sep 2019 (International)
  • Head of Department -Department of Clinical Research (CIC)
    01 Aug 2016 - 31 Jul 2018 (University Malaya)
  • Chairman
    01 Feb 2017 - 31 Jul 2018 (University Malaya)
  • Committee Member - Faculty of Medicine Central Research Facilities (JFGPP)
    01 Mar 2017 - 31 Jul 2018 (University Malaya)
  • Head
    01 Jan 2016 - 31 Dec 2017 (Clinical Research Centre, Faculty of Medicine)
  • Member of Price Negotiation Committee - Renovation of Clinical Investigation Centre
    20 Apr 2016 - 20 Apr 2016 (University Malaya)
  • Manager
    01 Oct 2013 - 14 Aug 2015 (International)
  • Manager of Clinical Investigation Centre (CIC), Faculty of Medicine, University of Malaya
    01 Oct 2012 - 14 Aug 2015 (International)
  • Chairman of Tender Committee - Proposal for Renovation and Upgrading including Civil, Mechanical, Electrical and ICT Works for Clinical Investigation Centre (CIC) Premise at 2nd Floor, Nursing Educational Science Complex, University Malaya Medical Centre
    25 Apr 2014 - 31 Dec 2014 (University Malaya)
  • Founder President of Pharmacy Alumni Society,University of Malaya (PhAUM)
    09 Aug 2012 - 09 Feb 2013 (University Malaya)
  • Coordinator of Hospital Pharmacy Services module
    23 Jul 2011 - 01 Sep 2012 (Department of Pharmacy, Faculty of Medicine)
  • Advisor of Pharmacy Society, University of Malaya
    08 Feb 2005 - 19 Jan 2008 (University Malaya)
  • Academic Advisor
    08 Feb 2005 - 26 Dec 2007 (Department of Pharmacy, Faculty of Medicine)
  • Coordinator of Clinical Pharmacy & Therapeutics I module
    05 Feb 2005 - 26 Dec 2007 ()
  • Re-accreditation of UM Pharmacy Course (The accompanying lecturer for the visit by the Malaysian Pharmacy Board)
    16 Jul 2007 - 18 Jul 2007 (Department of Pharmacy, Faculty of Medicine)
  • Coordinator of Endocrine, Gastrointestinal System & Therapy module
    05 Feb 2005 - 26 Mar 2007 (Department of Pharmacy, Faculty of Medicine)
  • Coordinator of Health Supplements module
    05 Feb 2005 - 26 Mar 2007 (Department of Pharmacy, Faculty of Medicine)
  • Quality Manager
    08 Feb 2005 - 08 Jan 2007 (Department of Pharmacy, Faculty of Medicine)
  • Coordinator of Respiratory, Blood System & Therapy module
    05 Feb 2005 - 30 Jun 2006 (Department of Pharmacy, Faculty of Medicine)

MEMBERSHIPS

  • MEMBER, MEMBER
    2023 to present (National)
  • MEMBER, MEMBER
    2023 to present (International)
  • SAS EMINENT FELLOW MEMBERSHIP, FELLOW
    Since 2021 (International)
  • MALAYSIAN ENDOCRINE AND METABOLIC SOCIETY, MEMBER
    Since 2012 (National)
  • MALAYSIAN PHARMACEUTICAL SOCIETY, MEMBER
    Since 2006 (National)
  • MALAYSIAN DIABETES ASSOCIATION, LIFE MEMBER
    Since 2005 (National)
  • COMMITTEE MEMBER OF UM ICT , MEMBER
    2021 to 2022 (University)
  • EXPERT MEMBER FOR DEVELOPMENT OF PHARMACY EXPERTISE VIA SUBJECT MATTER EXPERT, ADVISORY BOARD
    2021 to 2022 (National)
  • BOARD MEMBERS OF AKADEMI PENGAJIAN MELAYU, UNIVERSITI MALAYA, ADVISORY BOARD
    2020 to 2022 (University)
  • EDITORIAL BOARD - MALAYSIAN JOURNAL OF PHARMACEUTICAL SCIENCES, ADVISORY BOARD
    2020 to 2022 (National)
  • MEMBER OF DRUG CONTROL AUTHORITY (DCA), ADVISORY BOARD
    2020 to 2022 (National)
  • MEMBER OF ASIAN COUNCIL OF SCIENCE EDITORS, MEMBER
    2021 to 2021 (International)
  • PHARMACY DEAN COUNCIL MEMBER, COMMITTEE MEMBER
    2020 to 2021 (National)
  • COMMITTEE MEMBER FOR EVALUATION OF RESEARCH FUNDING , COMMITTEE MEMBER
    2020 to 2021 (National)

AWARD AND STEWARDSHIP

  • Excellence Service Award
    2025, Universiti Malaya
  • Mps Outstanding Leadership Award 2024
    2024, Malaysian Pharmacists Society (MPS),  (National)
  • Excellence Service Award
    2022, Universiti Malaya
  • Appointed as Supervisor in World Class Professor Program
    2022, Esa Unggul University, Jakarta Indonesia,  (International)
  • Best Presentation in Additional Track
    2021, Monash University,  (International)
  • First Prize of The Best Oral Presentation Award
    2021, Monash University,  (International)
  • Excellence Service Award
    2020, Universiti Malaya
  • Committee Member for Evaluation of Research Funds
    2020, Department of Higher Education, Ministry of Higher Education Malaysia,  (National)
  • Members of Pharmacy Dean Council
    2020, Department of Higher Education, Ministry of Higher Education Malaysia,  (National)
  • Editorial Board- Malaysian Journal of Pharmaceutical Sciences
    2020, Universiti Sains Malaysia,  (National)
  • Biography Listed in Who's Who in The World 2020, Marquis Who's Who in The World, 2020
    2020, Marquis Who'S Who in The World,  (International)
  • Certificate of Excellent Service 2018
    2019, University of Malaya,  (University)
  • Certificate of Excellent Service
    2019, Universiti Malaya
  • K-novasi 2019
    2019, National University of Malaysia,  (National)
  • 2019 Albert Nelson Marquis Lifetime Achievement Award, Marquis Who's Who, 2019
    2019, Marquis Who'S Who,  (International)
  • Biography Listed in Who's Who in The World 2019, Marquis Who's Who in The World, 2019
    2019, Marquis Who's Who,  (International)
  • Certificate of Excellent Service 2017
    2018, University of Malaya,  (University)
  • Certificate of Excellent Service
    2018, Universiti Malaya
  • Certificate of Achievement of Iqvia Global Top Performing Sites (recognition of Superior Performance and Quality for Clinical Research) for Clinical Investigation Centre (cic) - 2017 and 2018
    2018, IQVIA,  (International)
  • Bentham Brand Ambassador
    2018, Bentham Science,  (International)
  • Top-10 2017 Iqvia Prime Sites in The World and Top 2017 Iqvia Malaysia Prime Sites for Clinical Investigation Centre (cic) [7th Position, in The Global Top-10 2017 Iqvia Prime Sites, 3rd Position, in The Top-5 2017 Iqvia Apac Prime Sites and 1st Position, in The 2017 Iqvia Malaysia Prime Sites]
    2018, IQVIA,  (International)
  • 2018 Albert Nelson Marquis Lifetime Achievement Award
    2018, Marquis Who's Who,  (International)
  • Biography Listed in Who's Who in The World 2018, Marquis Who's Who in The World, 2018, (international)
    2018, Marquis Who'S Who in The World,  (International)
  • Certificate of Excellent Service 2017
    2017, University of Malaya,  (University)
  • 2017 Albert Nelson Marquis Lifetime Achievement Award
    2017, Marquis Who's Who,  (International)
  • Excellence Service Award
    2016, Universiti Malaya
  • Inspire Site (investigator Networks, Site Partnerships and Infrastructure for Research Excellence) for Clinical Investigation Centre (cic)(international)
    2016, Pfizer Inc,  (International)
  • Excellence Service Award (apc) 2016
    2016, University of Malaya,  (International)
  • Next Generation Scientist Program 2016 in Basel, Switzerland - Awarded to My Ph.d Student (navin Kumar S/o Loganadan)
    2016, Novartis Pharma AG, Basel Switzerland,  (International)
  • Certificate of Excellent Service
    2015, Universiti Malaya
  • UM Excellence Award
    2015, Universiti Malaya
  • Inspire Site (investigator Networks, Site Partnerships and Infrastructure for Research Excellence) for Clinical Investigation Centre (cic)(international)
    2015, Pfizer Inc,  (International)
  • Best Poster Award - 8th Euro Global Diabetes Summit and Medicare Expo - November 03-05, 2015- Valencia, Spain
    2015, Omics International,  (International)
  • University of Malaya Excellence Award 2015 (best Academic Administrator)
    2015, University of Malaya,  (University)
  • Biography Listed in Who's Who in The World 2016 (33rd Edition)
    2015, Marquis Who's Who in the World,  (International)
  • Top 100 Health Professionals 2015
    2015, International Biographical Centre, Cambridge, England,  (International)
  • The Only Prime Site in The Asia Pacific Region That Has All New Studies Recruit The First Patient Within 100 Days in 2014 for Clinical Investigation Centre (cic)
    2015, Quintiles,  (International)
  • Excellence Service Certificate (spc) 2015
    2015, University of Malaya,  (University)
  • Certificate of Excellent Service
    2014, Universiti Malaya
  • Inspire Site (investigator Networks, Site Partnerships and Infrastructure for Research Excellence) for Clinical Investigation Centre (cic)(international)
    2014, Pfizer Inc,  (International)
  • Biography Listed in Who's Who in The World 2015 (32nd Edition)
    2014, Marquis Who's Who in the World,  (International)
  • Excellence Service Certificate (spc) 2014
    2014, University of Malaya,  (University)
  • Excellence Service Award
    2013, Universiti Malaya
  • Best Prime Site in The World in Study Subject RecrUiTMent Number At The Half-year Mark of 2013; for Clinical Investigation Centre (cic)
    2013, Quintiles (International),  (International)
  • Asian Manufacturing Awards; Pharmaceutical Industry (best Pharma Clinical Trials Service Provider) for Clinical Investigation Centre (cic)(international)
    2013, Contineo Media Pte Ltd,  (International)
  • Inspire Site (investigator Networks, Site Partnerships and Infrastructure for Research Excellence) for Clinical Investigation Centre (cic)(international)
    2013, Pfizer Inc,  (International)
  • Excellence Service Award (apc) 2013
    2013, University of Malaya,  (University)
  • Best Oral Presenter (ph.d Category)
    2011, The National University of Malaysia,  (University)
  • Biolnno Award 2010
    2010, MOSTI (International),  (International)
  • Biolnno Awards 2009
    2009, MOSTI (International),  (International)
  • Invention, Innovation and Technology Exhibition (itex) 2008
    2008, Malaysian Invention and Design Society (MINDS) (International),  (International)
  • Malaysian Technology Expo (mte) 2007
    2007, Malaysian Association of Research Scientists (MARS),  (National)

PUBLICATIONS

Article in Journal
WoS
  1. Gacem, Sabrina Ait; Huri, Hasniza Zaman; Wahab, Izyan A.; Abduelkarem, Abduelmula R. (2025). Investigating digital determinants shaping pharmacists' preparedness for interoperability and health informatics practice evolution: a systematic review, INTERNATIONAL JOURNAL OF CLINICAL PHARMACY. . doi:10.1007/s11096-024-01851-6
  2. Sari, Kartika Citra Dewi Permata; Setiati, Adelia Nathifa Rachma Nur; Kusumawardani, Larasati Arrum; Huri, Hasniza Zaman; Elnaem, Mohamed Hassan (2025). The urge for specific standards of telepharmacy services: Lessons learned from qualitative study in Indonesian community pharmacies, DIGITAL HEALTH. 11. doi:10.1177/20552076251326018
  3. Ali, Majid; Wahab, Izyan Binti A.; Huri, Hasniza Zaman; Yusoff, Muhamad Saiful (2024). Personalised learning in higher education for health sciences: a scoping review protocol, SYSTEMATIC REVIEWS. 13(1). doi:10.1186/s13643-024-02478-4
  4. Degaga, Abraham; Sirgu, Sisay; Huri, Hasniza Zaman; Sim, Maw Shin; Loganadan, Navin Kumar; Kebede, Tedla; Tegene, Birhanemeskel; Engidawork, Ephrem; Shibeshi, Workineh (2024). Association of the Reduced Function Met420del Polymorphism of SLC22A1 with Metformin-Induced Gastrointestinal Intolerance in Ethiopian Patients with Type 2 Diabetes Mellitus, PHARMACOGENOMICS & PERSONALIZED MEDICINE. 17, 183-191. doi:10.2147/PGPM.S457374
  5. Gacem, Sabrina Ait; Huri, Hasniza Zaman; Wahab, Izyan A.; Abduelkarem, Abduelmula R. (2024). Patient-centric decision-making in supplements intake and disclosure in clinical practice: a novel SIDP-12 tool to prevent drug-supplement interaction, THERAPEUTIC ADVANCES IN DRUG SAFETY. 15. doi:10.1177/20420986241294150
  6. Hassanein, Mohammed M.; Huri, Hasniza Zaman; Abduelkarem, Abduelmula R. (2024). The impact of perceived vaginal and urinary symptoms and treatment burden in predicting sexual functioning among perimenopausal and postmenopausal women, INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS. . doi:10.1002/ijgo.15736
  7. Hassanein, Mohammed M.; Huri, Hasniza Zaman; Baig, Kauser; Abduelkarem, Abduelmula R.; Al-Momani, Marwan (2024). Development and validation of the genitourinary syndrome of menopause symptoms and vaginal treatments acceptability questionnaire (GSM-SVTAQ): An electronic patient-reported outcomes measure, INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS. . doi:10.1002/ijgo.15106
  8. Mohamed, W. A. S.; Ishak, K. N.; Baharum, N.; Zainudin, N. A. Z.; Lim, Han Yin; Noh, M. F. M.; Ahmad, W. A. W.; Huri, H. Zaman; Zuhdi, A. S. M.; Sukahri, S.; Govindaraju, K.; Abd Jamil, A. H. (2024). Ethnic disparities and its association between epicardial adipose tissue thickness and cardiometabolic parameters, ADIPOCYTE. 13(1). doi:10.1080/21623945.2024.2314032
  9. Rana, Rajat; Bin Ibrahim, Baharudin; Huri, Hasniza Binti Zaman; Wahab, Izyan Binti A.; Govindaraju, Kayatri; Shukeri, Mohd Syamir Mohamad; Ng, Chow Kyn; Ong, Siew Chin (2024). Development and validation of the mobile adherence satisfaction scale (MASS) for medication adherence apps, RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY. 20(10), 959-968. doi:10.1016/j.sapharm.2024.07.004
  10. Sharafaldin, Esra Nasraldin Khalil; Sim, Maw Shin; Lim, Soo Kun; Alhussieni, Kawthar; Huri, Hasniza Zaman (2024). Precision medicine in lupus nephritis, CLINICA CHIMICA ACTA. 562. doi:10.1016/j.cca.2024.119894
  11. Abousheishaa, Aya Ahmed; Lazim, Nor Hazila Mat; Tang, Song Ling; Sulaiman, Ahmad Hatim; Huri, Hasniza Zaman; Guan, Ng Chong (2023). Antidepressant decision aid for major depressive disorder patients (ADAM): Development and pilot testing (vol 105, pg 2466, 2022), PATIENT EDUCATION AND COUNSELING. 114. doi:10.1016/j.pec.2023.107852
  12. Eff, Aprilita Rina Yanti; Huri, Hasniza Zaman; Radji, Maksum; Munim, Abdul; Suyatna, F. D.; Eden, Yonatan (2023). Angiotensin converting enzyme (ACE) inhibitors activity from purified compounds Fructus Phaleria macrocarpa (Scheff) Boerl, BMC COMPLEMENTARY MEDICINE AND THERAPIES. 23(1). doi:10.1186/s12906-023-03889-x
  13. Hassanein, Mohammed M.; Huri, Hasniza Zaman; Abduelkarem, Abduelmula R.; Baig, Kauser (2023). Therapeutic Effects of Vitamin D on Vaginal, Sexual, and Urological Functions in Postmenopausal Women, NUTRIENTS. 15(17). doi:10.3390/nu15173804
  14. Hassanein, Mohammed M.; Huri, Hasniza Zaman; Baig, Kauser; Abduelkarem, Abduelmula R. (2023). Determinants and Effects of Vitamin D Supplementation in Postmenopausal Women: A Systematic Review, NUTRIENTS. 15(3). doi:10.3390/nu15030685
  15. Mohamed, W. A. S.; Ishak, K. N.; Huri, H. Z.; Jaharudin, A. F.; Zuhdi, A. S. M.; Sukahri, S.; Jamil, A. H. A. (2023). The associations of cardiac functions with glycaemic control parameters in type 2 diabetic (T2DM) patients with coronary artery disease (CAD) following sodium-glucose cotransporter-2 (SGLT-2) inhibitors: A preliminary quasi-experimental cohort analysis, INTERNATIONAL JOURNAL OF CARDIOLOGY. 393. doi:10.1016/j.ijcard.2023.131487
  16. Mohamed, W. A. S.; Jamil, H. A.; Huri, H. Z.; Zuhdi, A. S. M. (2023). The effects of SGLT-2 inhibitor on epicardial adipose tissue (EAT) thickness in general cardiology admission patient, INTERNATIONAL JOURNAL OF CARDIOLOGY. 393. doi:10.1016/j.ijcard.2023.131519
  17. Mokhtar, Fadzlin Mohd; Rajakumar, Sutha; Zaman Huri, Hasniza (2023). Adherence tool for prophylactic haemophilia treatment in adult and adolescent patients: A systematic review and meta-analysis protocol, PLOS ONE. 18(12). doi:10.1371/journal.pone.0289815
  18. Perumalsamy, Sangeetha; Huri, Hasniza Zaman; Abdullah, Bashar Mudhaffar; Mazlan, Othman; Ahmad, Wan Azman Wan; Vethakkan, Shireene Ratna D. B. (2023). Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease, METABOLITES. 13(3). doi:10.3390/metabo13030427
  19. Sharafaldin, Esra Nasraldin Khalil; Huri, Hasniza Zaman; Sim, Maw Shin; Lim, Soo Kun (2023). Potential immunological and genetic markers associated with lupus nephritis: From pathogenicity to therapeutic drug target, AUTOIMMUNITY REVIEWS. 22(12). doi:10.1016/j.autrev.2023.103406
  20. Yugavathy, Nava; Abdullah, Bashar Mudhaffar; Lim, Soo Kun; Gafor, Abdul Halim Bin Abdul; Wong, Muh Geot; Bavanandan, Sunita; Wong, Hin Seng; Huri, Hasniza Zaman (2023). Precision Medicine in Erythropoietin Deficiency and Treatment Resistance: A Novel Approach to Management of Anaemia in Chronic Kidney Disease, CURRENT ISSUES IN MOLECULAR BIOLOGY. 45(8), 6550-6563. doi:10.3390/cimb45080413
  21. Abousheishaa, Aya Ahmed; Lazim, Nor Hazila Mat; Tang, Song Ling; Sulaiman, Ahmad Hatim; Huri, Hasniza Zaman; Guan, Ng Chong (2022). Antidepressant decision aid for major depressive disorder patients (ADAM): Development and pilot testing, PATIENT EDUCATION AND COUNSELING. 105(7), 2466-2474. doi:10.1016/j.pec.2021.11.007
  22. Abousheishaa, Aya Ahmed; Sulaiman, Ahmad Hatim; Huri, Hasniza Zaman; Kamis, Siti Fatimah Binti; Hamidi, Hafizah; Ang, Wei Chern; bin Zainal, Zainol Akbar; Shamsuddin, Noorasyikin; Guan, Ng Chong (2022). Psychiatric pharmaceutical care service across Malaysian hospitals: results from a cross-sectional study, BMC HEALTH SERVICES RESEARCH. 22(1). doi:10.1186/s12913-022-07681-4
  23. Lin, S. N.; Chee, H.; Huri, H. Zaman; Toh, H. (2022). Insulin therapy associated with deterioration in left ventricular ejection fraction in heart failure patients with type 2 diabetes, INTERNATIONAL JOURNAL OF CARDIOLOGY. 369, 27-28. doi:10.1016/j.ijcard.2022.10.082
  24. Tee, Khim Boon; Ibrahim, Luqman; Hashim, Najihah Mohd; Saiman, Mohd Zuwairi; Zakaria, Zaril Harza; Huri, Hasniza Zaman (2022). Pharmacokinetic-Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes, PHARMACEUTICS. 14(6). doi:10.3390/pharmaceutics14061268
  25. Tee, Khim Boon; Ibrahim, Luqman; Hashim, Najihah Mohd; Saiman, Mohd Zuwairi; Zakaria, Zaril Harza; Huri, Hasniza Zaman (2022). Pharmacokinetics and Metabolomic Profiling of Metformin and Andrographis paniculata: A Protocol for a Crossover Randomised Controlled Trial, JOURNAL OF CLINICAL MEDICINE. 11(14). doi:10.3390/jcm11143931
  26. Wahab, Izyan A. A.; Goh, Khang Wen; Zainal, Zainol Akbar; Yusof, Najlaa Siham Mohamed Mohamed; Huri, Hasniza Zaman; Jacob, Sabrina Anne; Alwi, Muhammad Najib Mohamad Mohamad; Hashim, Rosnani; Hisham, Shairyzah Ahmad Ahmad; Jamil, Nurdiana (2022). Targeted Primary and Secondary Preventive Strategies for Depression among Malaysian Pharmacy Students, INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 19(15). doi:10.3390/ijerph19159629
  27. Boon, Tee Khim; Huri, Hasniza Zaman; Hashim, Najihah Mohd; Ibrahim, Luqman; Saiman, Mohd Zuwairi; Zakaria, Zaril Harza; Sakika, Kasful Asra; Hisham, Syaza Fatnin; Mansor, Azwa (2021). Pharmacometabolomics of Meformin Demonstrated Insulin Sensitivity Related Pathways at Peak Plasma Concentration on Healthy Volunteers - Preliminary Results, METABOLISM-CLINICAL AND EXPERIMENTAL. 116, 28-28. doi:10.1016/j.metabol.2020.154536
  28. Elnaem, M. H., Kamarudin, N. H., Syed, N. K., Huri, H. Z., Dehele, I. S., & Cheema, E. (2021). Associations between Socio-Demographic Factors and Hypertension Management during the COVID-19 Pandemic: Preliminary Findings from Malaysia. International journal of environmental research and public health, 18(17), 14. doi: 10.3390/ijerph18179306
  29. Loganadan, N. K., Huri, H. Z., Vethakkan, S. R., & Hussein, Z. (2021). Pharmacogenetics of sulfonylurea-induced hypoglycemia in Type 2 diabetes patients: the SUCLINGEN study. Pharmacogenomics, 22(16), 1057-1068. doi: 10.2217/pgs-2021-0059
  30. Mokhtar, Fadzlin Mohd; Sathar, Jameela; Huri, Hasniza Zaman (2021). Medication Adherence for Haemophilia Patients: Outcome of Prophylaxis Treatment Intervention, HEALTHCARE. 9(12). doi:10.3390/healthcare9121702
  31. Perumalsamy, S., Ahmad, W. A. W., & Huri, H. Z. (2021). Retinol-Binding Protein-4-A Predictor of Insulin Resistance and the Severity of Coronary Artery Disease in Type 2 Diabetes Patients with Coronary Artery Disease. Biology-Basel, 10(9), 16. doi: 10.3390/biology10090858
  32. Perumalsamy, S., Ahmad, W. A. W., & Huri, H. Z. (2021). Single Nucleotide Polymorphism rs17173608 in the Chemerin Encoding Gene: Is It a Predictor of Insulin Resistance and Severity of Coronary Artery Disease in Non-Obese Type 2 Diabetes? Healthcare, 9(6), 15. doi: 10.3390/healthcare9060623
  33. Perumalsamy, Sangeetha; Huri, Hasniza Zaman; Ahmad, Wan Azman Wan (2021). Association of YKL-40 Encoding Gene CHI3L1 rs946263 with Insulin Resistance and Severity of Coronary Artery Disease in Type 2 Diabetes Mellitus Patients, METABOLISM-CLINICAL AND EXPERIMENTAL. 116, 22-22. doi:10.1016/j.metabol.2020.154520
  34. Zaini, S., Sulaiman, A. H., Huri, H. Z., Koh, O. H., Gill, J. S., Francis, B., . . . Guan, N. C. (2021). Patient-Centred Communication in the Use of Antidepressants among People with Depression: A Scoping Review. Sains Malaysiana, 50(1), 161-170. doi: 10.17576/jsm-2021-5001-16
  35. Abousheishaa, A. A., Sulaiman, A. H., Huri, H. Z., Zaini, S., Othman, N. A., bin Aladdin, Z., & Guan, N. C. (2020). Global Scope of Hospital Pharmacy Practice: A Scoping Review. Healthcare, 8(2), 14. doi: 10.3390/healthcare8020143
  36. Lin, S. N., Phang, K. K., Toh, S. H., Chee, K. H., & Huri, H. Z. (2020). Heart Failure With Type 2 Diabetes Mellitus: Association Between Antihyperglycemic Agents, Glycemic Control, and Ejection Fraction. Frontiers in Endocrinology, 11, 10. doi: 10.3389/fendo.2020.00448
  37. Loganadan, N. K., Huri, H. Z., Vethakkan, S. R., & Hussein, Z. (2020). Clinical and genetic predictors of secondary sulfonylurea failure in Type 2 diabetes patients: the SUCLINGEN study. Pharmacogenomics, 21(9), 587-600. doi: 10.2217/pgs-2019-0171
  38. Yugavathy, N., Huri, H. Z., Kun, L. S., Gafor, A. H. B., Geot, W. M., Bavanandan, S., & Seng, W. H. (2020). Clinical and genetic markers of erythropoietin deficiency anemia in chronic kidney disease (predialysis) patients. Biomarkers in Medicine, 14(12), 1099-1108. doi: 10.2217/bmm-2020-0205
  39. Elnaem, M. H., Mohamed, M. H. N., Huri, H. Z. (2019). Pharmacist-led academic detailing improves statin therapy prescribing for Malaysian patients with type 2 diabetes: Quasi-experimental design. Plos One, 14(9), 13. doi: 10.1371/journal.pone.0220458
  40. Elnaem, M. H., Mohamed, M. H. N., Huri, H. Z., Shah, A. S. M. (2019). Effectiveness and prescription pattern of lipid-lowering therapy and its associated factors among patients with type 2 diabetes mellitus in Malaysian primary care settings. Therapeutics and Clinical Risk Management, 15, 137-145. doi:10.2147/tcrm.s182716
  41. Ma, S. N., Huri, H. Z., Yahya, F. (2019). Drug-related problems in patients with rheumatoid arthritis. Therapeutics and Clinical Risk Management, 15, 505-524. doi:10.2147/tcrm.s194921
  42. Abu Bakar, M. H., Hairunisa, N., Huri, H. Z. (2018). Reduced mitochondrial DNA content in lymphocytes is associated with insulin resistance and inflammation in patients with impaired fasting glucose. Clinical and Experimental Medicine, 18(3), 373-382. doi:10.1007/s10238-018-0495-4
  43. Abu Bakar, M. H., Sarmidi, M. R., Cheng, K. K., Khan, A. A., Suan, C. L., Huri, H. Z., Yaakob, H. (2015). Metabolomics - the complementary field in systems biology: a review on obesity and type 2 diabetes. Molecular Biosystems, 11(7), 1742-1774.
  44. Abu Bakar, M. H., Sarmidi, M. R., Kai, C. K., Huri, H. Z., Yaakob, H. (2014). Amelioration of Mitochondrial Dysfunction-Induced Insulin Resistance in Differentiated 3T3-L1 Adipocytes via Inhibition of NF-kappa B Pathways, International Journal of Molecular Sciences. 15(12), 22227-22257
  45. Huri, H. Z., Xiang, L. T. (2014). Factors Associated with Treatment Response to Antidiabetic Agents in Compliant Type 2 Diabetes Mellitus Patients: A Brief Summary of 5-Year Data, Tropical Journal of Pharmaceutical Research. 13(3), 429-4351596-5996.
  46. Huri, H. Z., Choo, T. L., Sulaiman, C. Z., Mark, R., Razack, A. H. A. (2014). Oral drug treatments in patients with erectile dysfunction and multiple comorbidities: a retrospective observational study, Bmj Open. 4(7), 9
  47. Huri, H. Z., Xin, C. H., Sulaiman, C. Z. (2014). Drug-Related Problems in Patients with Benign Prostatic Hyperplasia: A Cross Sectional Retrospective Study, Plos One. 9(1), 14
  48. Huri, Hasniza Zaman; Permalu, Vishaaliny; Vethakkan, Shireene Ratna (2014). Sliding-Scale versus Basal-Bolus Insulin in the Management of Severe or Acute Hyperglycemia in Type 2 Diabetes Patients: A Retrospective Study, PLOS ONE. 9(9). doi:10.1371/journal.pone.0106505
  49. Jamaluddin, Jazlina Liza; Huri, Hasniza Zaman; Vethakkan, Shireene Ratna; Mustafa, Norlaila (2014). Pancreatic gene variants potentially associated with dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes, PHARMACOGENOMICS. 15(2), 235-249. doi:10.2217/pgs.13.234
  50. Sarker, M. M. R., Islam, K. N., Huri, H. Z., Rahman, M., Imam, H., Hosen, M. B., Mohammad, N., Sarker, M. Z. I. (2014). Studies of the Impact of Occupational Exposure of Pharmaceutical Workers on the Development of Antimicrobial Drug Resistance, Journal of Occupational Health. 56(4), 260-270
  51. Huri, H. Z., Ling, L. C. (2013). Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia, Bmc Public Health. 13, 13
  52. Huri, H. Z., Wee, H. F. (2013). Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study, Bmc Endocrine Disorders. 13, 12
  53. Ikmal, Sharifah Intan Qhadijah Syed; Huri, Hasniza Zaman; Vethakkan, Shireene Ratna; Ahmad, Wan Azman Wan (2013). Potential Biomarkers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease, INTERNATIONAL JOURNAL OF ENDOCRINOLOGY. 2013. doi:10.1155/2013/698567
  54. Huri, H. Z., Wei, A. T. L., Pendek, R., Sulaiman, C. Z., Widodo, R. T. (2010). Factors Influencing Utilization of Different Types of Sulphonylureas Amongst Type 2 Diabetes Patients, Latin American Journal of Pharmacy. 29(6), 1044-1048
  55. Huri, H. Z., Foong, G. T. K., Pendek, R., Widodo, R. T. (2009). Different characteristics of diabetic ketoacidosis between type 1 and type 2 diabetes patients in Malaysia, Asian Biomedicine. 3(2), 201-205
  56. Huri, H. Z., Wen, O. C., Pendek, R. (2008). Self-monitoring of blood glucose among type-2 diabetes patients in Malaysia, Asian Biomedicine. 2(1905-7415 ), 4
  57. Huri, H. Z., Min, Y. S., Pendek, R. (2007). Episodes of hypoglycemia and hyperglycemia during the use of sliding scale insulin in hospitalized diabetes patients, Asian Biomedicine. 1(3), 307-311
ESCI
  1. Abousheishaa, A. A., Sue-Yin, L., Khin, K. C., Sulaiman, A. H., Huri, H. Z., & Guan, N. C. (2021). A Clinical Practice Guideline Summary for Pharmacological Management of Adults with Major Depressive Disorder in Malaysia. Journal of Pharmaceutical Research International, 33(45B), 405-411. doi: 10.9734/JPRI/2021/v33i45B32821
Scopus
  1. Abousheishaa A.A., Lazim N.H.M., Tang S.L., Sulaiman A.H., Huri H.Z., Guan N.C. (2022). Antidepressant decision aid for major depressive disorder patients (ADAM): Development and pilot testing, Patient Education and Counseling. 105(7), 2466-2474. doi:10.1016/j.pec.2021.11.007
  2. Abousheishaa A.A., Sulaiman A.H., Huri H.Z., Kamis S.F.B., Hamidi H., Ang W.C., Zainal Z.A., Shamsuddin N., Guan N.C. (2022). Psychiatric pharmaceutical care service across Malaysian hospitals: results from a cross-sectional study, BMC health services research. 22(1), 321. doi:10.1186/s12913-022-07681-4
  3. Tee K.B., Ibrahim L., Hashim N.M., Saiman M.Z., Zakaria Z.H., Huri H.Z. (2022). Pharmacokinetic Pharmacometabolomic Approach in Early-Phase Clinical Trials: A Way Forward for Targeted Therapy in Type 2 Diabetes, Pharmaceutics. 14(6). doi:10.3390/pharmaceutics14061268
  4. Tee K.B., Ibrahim L., Hashim N.M., Saiman M.Z., Zakaria Z.H., Huri H.Z. (2022). Pharmacokinetics and Metabolomic Profiling of Metformin and Andrographis paniculata: A Protocol for a Crossover Randomised Controlled Trial, Journal of Clinical Medicine. 11(14). doi:10.3390/jcm11143931
  5. Wahab I.A., Goh K.W., Zainal Z.A., Yusof N.S.M., Huri H.Z., Jacob S.A., Alwi M.N.M., Hashim R., Hisham S.A., Jamil N. (2022). Targeted Primary and Secondary Preventive Strategies for Depression among Malaysian Pharmacy Students, International journal of environmental research and public health. 19(15). doi:10.3390/ijerph19159629
  6. Huri, H. Z., Wei, A. T. L., Pendek, R., Sulaiman, C. Z., Widodo, R. T. (2010). Factors influencing utilization of different types of sulphonylureas amongst type 2 diabetes patients, Latin American Journal of Pharmacy. 29(6), 1044-104803262383
  7. Huri, H. Z., Lian, G. T. P., Hussain, S., Pendek, R., Widodo, R. T. (2009). A survey amongst Complementary Alternative Medicine (CAM) users with type 2 diabetes, International Journal of Diabetes and Metabolism. 17(1), 9-15
  8. Huri, H. Z., Wen, O. C., Pendek, R. (2008). Self-monitoring of blood glucose among type-2 diabetes patients in Malaysia, Asian Biomedicine. 2(4), 335-340
  9. Zaman Huri, H., Lee, Q. Y., Pendek, R., Sulaiman, C. Z. (2008). Use of antiplatelet agents for primary and secondary prevention of cardiovascular disease amongst type 2 diabetic patients, Journal of Pharmacy Practice. 21(4), 287-301
Others
  1. Abraham Degaga, Sisay Sirgu, Hasniza Zaman Huri, Maw Shin Sim, Tedla Kebede, Birhanemeskel Tegene, Navin Kumar Loganadan, Ephrem Engidawork & Workineh Shibeshi (2023) Association of Met420del Variant of Metformin Transporter Gene SLC22A1 with Metformin Treatment Response in Ethiopian Patients with Type 2 Diabetes, Diabetes, Metabolic Syndrome and Obesity, 16:, 2523-2535, DOI: 10.2147/DMSO.S426632
  2. Nava Yugavathy, Hasniza Zaman Huri, Lim Soo Kun, Abdul Halim Bin Abdul Gafor, Wong Muh Geot, Sunita Bavanandan, Wong Hing Seng. Clinical and Genetic Marker of Erythropoietin Deficiency Anaemia in Chronic Kidney Disease (pre-dialysis) Patients. Biomark. Med. (2020) 14(12), 1099 1108
  3. Ma SN, Zaman Huri H, Yahya F. (2019). Drug-related problems in patients with rheumatoid arthritis.Therapeutics and Clinical Risk Management.
  4. Ma Shu Ning, Hasniza Zaman Huri. Fariz Yahya. Drug Related Problems in Patients with Rheumatoid Arthritis. Therapeutics and Clinical Risk Management 2019:15 505 524
  5. Mohamed Hassan Elnaem, Mohamad Haniki Nik Mohamed, Hasniza Zaman Huri. Pharmacist-led Academic Detailing Improves Statin Therapy Prescribing for Malaysian Patients with Type 2 Diabetes: Quasi-Experimental Design. 2019; PLoS ONE 14(9): e0220458.
  6. Hasniza Zaman Huri, Chua Chew Huey, Norasyikin Mustafa, Nor Fadhilah Mohamed, Tengku Ain Fathlun. Association of glycaemic control and progression of diabetic retinopathy in type 2 diabetes mellitus patients. Braz. J. Pharm. Sci. 2018;54(2):e17484
  7. MH Elnaem, MH Nik Mohamed, HZ Huri, SM Azarisman. Impact of Educational Outreach Intervention on Enhancing Healthcare Providers Knowledge about Statin Therapy Prescribing in Malaysian Patients with Type 2 Diabetes Mellitus. J Eval Clin Pract. 2018 Jun;24(3):521-527. doi: 10.1111/jep.12903. Epub 2018 Mar 6.
  8. MH Elnaem, MH Nik Mohamed, HZ Huri, SM Azarisman. Patterns of statin therapy prescribing among hospitalized patients with Type 2 diabetes mellitus in two Malaysian tertiary hospitals. Tropical Journal of Pharmaceutical Research 2018 (accepted)
  9. Nor Razida Razali, Hasniza Zaman Huri, Luqman Ibrahim, Shireene Ratna Vethakkan, Bashar Mudhaffar Abdullah. Glycemic effects of simvastatin: Where do we stand? Braz. J. Pharm. Sci. 2018;54(1):e17192
  10. Ray Mond Mark, Hasniza Zaman Huri, Azad Hassan Abdul Razack. Demographic, Clinical and Lifestyle Predictors for Severity of Erectile Dysfunction and Biomarkers level in Malaysian Patients. Brazilian Journal of Pharmaceutical Sciences 2018 (accepted)
  11. Syahrir Zaini *, Harvin Anbu Manivanna Bharathy, Ahmad Hatim Sulaiman, Jesjeet Singh Gill, Koh Ong Hui, Hasniza Zaman Huri, Siti Hadijah Shamsudin, Ng Chong Guan.Development of a strategic tool for shared decision-making in the use of antidepressants among patients with major depressive disorder: A focus group study IJERPH (2018) - accepted
  12. Syahrir Zaini, NG Chong Guan , Ahmad Hatim Sulaiman, Nor Zuraida Zainal, Hasniza Zaman Huri, Siti Hadijah Shamsudin. The Use of Antidepressants for Physical and Psychological Symptoms in Cancer. Current Drug Target 2018 Feb 26. doi: 10.2174/1389450119666180226125026. [Epub ahead of print]
  13. Ying TJ, Zainal ZA, Wahab IA, Zamri F and Huri HZ. Attitude and Self-Medication practice on Antibiotic use amongst general public in Alor Setar, Kedah, Malaysia. Madridge J Pharm Res. 2018; 2(1): 40-46.
  14. Elnaem MH, Mohamed MH, Huri HZ, Azarisman SM, Elkalmi RM. Statin therapy prescribing for patients with type 2 diabetes mellitus: A review of current evidence and challenges. J Pharm Bioall Sci 2017;9:80-7.
  15. Hasniza Zaman Huri, Ling Chui Fang, Azad Hassan Abdul Razack (2017). Drug-related problems in patients with erectile dysfunctions and multiple co-morbidities. Therapeutics and Clinical Risk Management,13, 407 419.
  16. Maryam Abbaspour Babaei, Hasniza Zaman Huri, Behnam Kamalidehghan, Swee Keong Yeap, Fatemeh Ahmadipour. Apoptotic induction and inhibition of NF- B signaling pathway in human prostatic cancer PC3 cells by natural compound 2,2 -oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea costalis : an in vitro study. OncoTargets and Therapy 2017:10 277 294.
  17. Mohamad Hafizi Abu Bakar, Hasniza Zaman Huri, Nany Hairunisa. Alterations of cultured myotubes and fasting plasma metabolite profiles related to mitochondrial dysfunction in Type 2 diabetes subjects. Free Radical Biology and Medicine, July 2017 Vol 108, Supplement 1, S24.
  18. Radwan H. Ahmed, Hasniza Zaman Huri, Sekaran Muniandy, Zaid Al-Hamodi, Boshra Al-absi, Abdulsamad Alsalahi, Muhammad Fazril Mohamad Razif. Altered Circulating Concentrations Of Active Glucagon-Like Peptide (GLP-1) And Dipeptidyl Peptidase 4 (DPP4) In Obese Subjects And Their Association With Insulin Resistance - Clinical Biochemistry (2017) - http://dx.doi.org/10.1016/j.clinbiochem.2017.03.008
  19. Sangeetha Perumalsamy,1 Nurul Ain Aqilah Mohd Zin,1 Riyanto Teguh Widodo,1 Wan Azman Wan Ahmad,3 Shireene Ratna DB Vethakkan,4 Hasniza Zaman Huri*1,2. Chemokine like receptor- 1 (CMKLR-1) receptor: A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and Cancer. Curr Pharm Des. 2017 Jun 15. doi: 10.2174/1381612823666170616081256.
  20. Syahrir Zaini, Ng Chong Guan, Ahmad Hatim Sulaiman, Hasniza Zaman Huri, Siti Hadijah Shamsudin. A Review of The Use of Mirtazapine in Cancer Patients. Malaysian Journal of Psychiatry 2017; 01-08-16
  21. Baig S, Seevasant I, Mohamad J, Mukheem A, Huri HZ, Kamarul T. Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand? Cell Death Dis. 2016 Jan 14;7:e2058
  22. Bashar Mudhaffar Abdullah, Saiful Irwan Zubairi, Hasniza Zaman Huri,Nany Hairunisa, Emad Yousif, Roma Choudhury Basu. Polyesters Based on Linoleic Acid for Biolubricant Basestocks: Low Temperature,Tribological and Rheological Properties. PLOS ONE | DOI:10.1371/journal.pone.0151603 March 23, 2016
  23. Hasniza Zaman Huri, Muhammad Irfan Abdul Aziz, Shireene Ratna Vethakkan, Riyanto Teguh Widodo.Factors Associated with Hypoglycemia Episodes In Hospitalised Type 2 Diabetes Mellitus Patients. Trop J Pharm Res 2016; 15 (6): 1313-1320
  24. Hasniza Zaman Huri, Nurul Diyana Mat Sanusi, Azad Hassan Abdul Razack, Raymond Mark. Association of psychological factors, patients knowledge, and management among patients with erectile dysfunction. Patient Preference and Adherence 2016:10 807 823
  25. Huri HZ, Mat Sanusi ND, Razack AHA, Mark R. (2016). Association of psychological factors, patients' knowledge and management among patients with erectile dysfunction. Patient Preference and Adheranace, 10 (807-823)
  26. Jazlina Liza Jamaluddin, Hasniza Zaman Huri. Shireene Ratna Vethakkan. Clinical and genetic predictors of dipeptidyl peptidase-4 inhibitor treatment response in type 2 diabetes mellitus. Pharmacogenomics 2016 (accepted).
  27. Krisna Veni Balakrishnan, Bashar Mudhaffar Abdullah, Raghda Alsayed, Hasniza Zaman Huri, Nany Hairunisa, Ammal Esmaeel Ibrahim, and Emad Yousif. A Study on Cloning and Expression of HIV A Study on Cloning and Expression of HIVA Study on Cloning and Expression of HIV by Transient Transfection. Research Journal of Pharmaceutical, Biological and Chemical Sciences. November December 2016 RJPBCS 7(6) Page No. 1318-1330.
  28. Maryam Abbaspour Babaei, Behnam Kamalidehghan, Mohammad Saleem, Hasniza Zaman Huri, Fatemeh Ahmadipour. Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells. Drug Design, Development and Therapy 2016:10 2443 2459.
  29. Maryam Abbaspour Babaei, Hasniza Zaman Huri, Behnam Kamalidehghan, Yeap Swee Keong, Fatemeh Ahmadipour. Apoptotic induction and inhibition of NF- B signaling pathway in human prostatic cancer PC3 cells by natural Compound 2,2'-Oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea Costalis: an in vitro study. OncoTargets and Therapy 2016 (accepted)
  30. Navin K. Loganadan. Hasniza Zaman Huri, Shireene R. Vethakkan, Zanariah Hussein. 2016. Association of rs5219 KCNJ11 Gene Polymorphism with Pancreatic Beta-Cell Function, Insulin Resistance, and Glycemic Control of Sulfonylurea-treated Malaysian Type 2 Diabetes Patients. Diabetes. 65 (1). A428
  31. Navin Kumar Loganadan, Hasniza Zaman Huri, Shireene Ratna Vethakkan and Zanariah Hussein. Genetic markers predicting sulphonylurea treatment outcomes in Type 2 Diabetes patients: current evidence and challenges for clinical implementation. The Pharmacogenomics Journal (Nature Publishing Group) (2016), 1-11.
  32. Nor Bahirah Kasim, Hasniza Zaman Huri, Shireene Ratna Vethakkan, Luqman Ibrahim, Bashar Mudhaffar Abdullah. Genetic Polymorphisms Associated with Overweight and Obesity in Uncontrolled Type 2 Diabetes Mellitus. Biomarkers in Medicine - 10.2217/bmm-2015-0037 2016 Future Medicine Ltd
  33. Radwan H. Ahmed, Hasniza Zaman Huri, Zaid Al-Hamodi, Sameer D. Salem, Boshra Al-absi, Sekaran Muniandy. Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian subjects. PLoS ONE 11(4): e0154369. doi:10.1371/journal.pone.0154369 (2016)
  34. Abu Bakar MH, Sarmidi MR, Yaakob H, Kai CK, HZ Huri. JNK Signaling Pathways Is Required For Mitochondrial Dysfunction-Induced Insulin Resistance In WRL-68 Human Liver Cell. Diabetes Technology & Therapeutics. Vol 17 (1): A154-155.
  35. Celastrol Protects Against Antimycin A-induced Insulin Resistance in Human Skeletal Muscle Cells. Mohamad Hafizi Abu Bakar, Kian-Kai Cheng, Mohamad Roji Sarmidi,Harisun Yaakob, Hasniza Zaman Huri. Molecules 2015; accepted
  36. Firas Hassan, Ayah Abdul Hameed, Ahemd Alshanon, Bashar Mudhaffar Abdullah,Hasniza Zaman Huri, Nany Hairunisa and Emad Yousif. Antitumor Activity for Gold (III) Complex by High Content Screening Technique (HCS) and Cell Viability Assay. Asian Journal of Biochemistry 10 (6): 252-266, 2015
  37. Hasniza Zaman Huri, Doris Ling Yew Hui, Wan Azman Wan Ahmad. Association between glycemic control and anti-diabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications. Drug Design, Development and Therapy (May 2015) - accepted
  38. Hasniza Zaman Huri, Lim Lay Peng, Lim Soo Kun. Glycaemic Control and Antidiabetic Drugs in Type 2 Diabetes Mellitus Patients with Renal Complications. Drug Design, Development and Therapy 2015 (accepted)
  39. Huri HZ, Lim LP, Lim SK. Glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications. Drug Des Devel Ther. 2015 Aug 7;9:4355-71.
  40. J.L. Jamaluddin, H.Z. Huri, S.R. Vethakkan, N. Mustafab,W.A.W. Ahmad. Pathway Mechanism of Potential Genomic Markers of Dipeptidyl Peptidase-4 Inhibitor Treatment Response in Type 2 Diabetes. Public Health Genomics 2015;18(suppl 1):1 51(DOI: 10.1159/000381430)
  41. Krisna Veni Balakrishnan, Bashar Mudhaffar Abdullah, Hasniza Zaman Huri,Nany Hairunisa and Narazah Mohd Yusoff. A Review on Biologically Active N-Myristoylated HIV-1 Nef Protein. Asian Journal of Biochemistry 10 (6): 242-251, 2015
  42. Mohamad Hafizi Abu Bakar, Cheng Kian Kai,Wan Najihah Wan Hassan,Mohamad Roji Sarmidi, Harisun Yaakob, Hasniza Zaman Huri. Mitochondrial Dysfunction as a Central Event for Mechanisms Underlying Insulin Resistance: The Roles of Long Chain Fatty Acids, Diabetes/Metabolism Research and Reviews (in press)
  43. Mohamad Hafizi Abu Bakar, Mohamad Roji Sarmidi, Kian Kai Cheng, Abid Ali Khan, Lee Suan Chua, Hasniza Zaman Huri, Harisun Yaakob. Metabolomics The Complementary Field in Systems Biology: A Review on Obesity and Type 2 Diabetes. Molecular BioSystems 04/2015; DOI: 10.1039/C5MB00158G
  44. N.K. Loganadan, H.Z. Huri, S.R. Vethakkan, Z. Hussein. Impact of Single Nucleotide Polymorphisms(SNPs) of Type 2 Diabetes (T2D) Genes on Patients Response to Sulphonylurea Therapy.Public Health Genomics 2015;18 (suppl 1):1 51 (DOI: 10.1159/000381430)
  45. R.H. Ahmed, Z. Al-Hamodi, S.D. Salem, H.Z. Huri, S. Muniandy. Association of Genetic Polymorphisms of Dipeptidyl Peptidase-4 with Metabolic Syndrome Parameters in Malaysian Subjects. Public Health Genomics 2015;18(suppl 1):1 51 (DOI: 10.1159/000381430)
  46. Radwan H. Ahmed, Hasniza Zaman Huri, Zaid Al-Hamodi, Sameer. D. Salem and Sekaran Muniandy. The Serum Level of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian Subjects. PLos One (accepted October 2015)
  47. Yasmin Almualm, Hasniza Zaman Huri. Chronic Kidney Disease Screening Methods and Its Implication for Malaysia: An in Depth Review. Global Journal of Health Science; Vol. 7, No. 4; 2015
  48. Darfizzi Derawi,Bashar Mudhaffar Abdullah, Hasniza Zaman Huri,Rahimi M. Yusop, Jumat Salimon, Nany Hairunisa. Palm Olein as Renewable Raw Materials for Industrial and Pharmaceutical Products Applications: Chemical Characterization and Physicochemical Properties Studies; Advances in Materials Science and Engineering (accepted)
  49. Hasniza Zaman Huri, Lee Tze Xiang. Factors Associated With Treatment Response To Antidiabetic Agents In Compliant Type 2 Diabetes Mellitus Patients: A Brief Summary Of 5 Years' Data; Trop J Pharm Res 2014;13(3): 429-435.
  50. Hasniza Zaman Huri, Mohd Makmor-Bakry, Rosnani Hashim, Norlaila Mustafa, Wan Zurinah Wan Ngah. A Prospective Cohort Study of IRS Genes Polymorphisms in Type 2 Diabetes Mellitus Patients during Severe/Acute Hyperglycemia Phase: Part 1: Association with Insulin Resistance. Trop J Pharm Res 2014; 13(6): 895-901.
  51. Hasniza Zaman Huri, Mohd Makmor-Bakry, Rosnani Hashim, Norlaila Mustafa, Wan Zurinah Wan Ngah. A Prospective Cohort Study of IRS Genes Polymorphisms in Type 2 Diabetes Mellitus Patients during Severe/Acute Hyperglycemia Phase: Part 2: Association with Glycemic Control. Trop J Pharm Res 2014; 13(6):903-906.
  52. Hasniza Zaman Huri, Mohd Makmor-Bakry, Rosnani Hashim, Norlaila Mustafa, Wan Zurinah Wan Ngah. Effect of Interaction between Polymorphisms in the Insulin Receptor Substrate Genes in Type 2 Diabetes Mellitus Patients with Severe/Acute Hyperglycemia. Trop J Pharm Res 2014; 13(6): 889-894.
  53. Hasniza Zaman Huri, NorFarahen Selamat, Shireene Ratna Vethakkan. Factors Associated with Utilization of Dipeptidyl-4 Inhibitors in Patients with Type 2 Diabetes Mellitus: A Cross-sectional Retrospective Study. Int J Endocrinol. 2014: 367564. Published online Sep 2, 2014. doi: 10.1155/2014/367564
  54. Hasniza Zaman Huri, Tee Lian Choo, Che Zuraini Sulaiman, Raymond Mark, Azad Hassan Abdul Razack. Oral Drug Treatments in Subjects with Erectile Dysfunction and Multiple Comorbidities: A Retrospective Observational Study. BMJ Open;4(7)2014 - doi:10.1136/bmjopen-2014-005381
  55. Hasniza Zaman Huri, Vishaaliny Permalu, Shireene Ratna Vethakkan. Sliding-scale versus basal-bolus insulin in the management of severe or acute hyperglycemia in type 2 diabetes patients: A retrospective study. P
  56. Hasniza Zaman Huri, Vishaaliny Permalu, Shireene Ratna Vethakkan. Sliding-scale versus basal-bolus insulin in the management of severe or acute hyperglycemia in type 2 diabetes patients: A retrospective study. PLos ONE (accepted)
  57. Md. Moklesur Rahman Sarker, Kamrun Nahar Islam, Hasniza Zaman Huri, Monzur Rahman, Hasan Imam, Md. Biplob Hosen, and Nur Mohammad. Studies of the impact of occupational exposure on pharmaceutical workers to the development of antimicrobial drug resistance. Journal of Occupational Health 2014; accepted.
  58. Mohamad Hafizi Abu Bakar, Mohamad Roji Sarmidi, Cheng Kian Kai, Hasniza Zaman Huri, Harisun Yaakob. Amelioration of Mitochondrial Dysfunction- induced Insulin Resistance in Differentiated 3T3-L1 Adipocytes via Inhibition of NF-ĪŗB Pathways. International Journal of Molecular Sciences 2014 (accepted)
  59. Syed Ikmal SI, Zaman Huri H, Vethakkan SR, Wan Ahmad, WA. Potential biomarkers for insulin resistance and atherosclerosis among type 2 diabetes mellitus patients with coronary artery disease. Obesity Reviews 15 (Supp.2), 72, March 2014.
  60. Hasniza Zaman Huri, Ho Fun Wee. 2013,13:2. Drug Related Problems in Type 2 Diabetes Patients With Hypertension: A Cross-Sectional Retrospective Study. BMC Endocrine Disorders; doi:10.1186/1472-6823-13-2
  61. Hasniza Zaman Huri, Lee Chai Ling. Drug-Related Problems in Type 2 Diabetes Mellitus Patients with Dyslipidemia. BMC Public Health 2013, 13:1192 doi:10.1186/1471-2458- 13-1192
  62. Hasniza Zaman Huri, Vishaaliny Permalu, Nor Bahirah Kasim. Management of severe/acute hyperglycemia in hospitalised type 2 diabetes mellitus patients. Journal of Endocrinology and Diabetes Mellitus: 2013 (1)No.1: 9- 14.
  63. Huri HZ, Makmor-Bakry M, Hashim R, Mustafa N, Wan Ngah WZ. Demographic and Clinical Predictors for Insulin Resistance in Type 2 Diabetes Mellitus Patients During Severe/Acute Hyperglycemia Phase. Lat. Am. J. Pharm. 32 (1): 120-7 (2013)
  64. Huri HZ, Makmor-Bakry M, Hashim R, Mustafa N, Wan Ngah WZ. Demographic and Clinical Predictors for Insulin Resistance in Type 2 Diabetes Mellitus Patients During Severe/Acute Hyperglycemia Phase. Lat Am J Pharm (accepted)
  65. Huri HZ, Makmor-Bakry M, Hashim R, Mustafa N & Wan Ngah WZ. Optimisation of glycaemic control during episodes of severe/acute hyperglycaemia in patients with type 2 diabetes mellitus. Int J Clin Pharm (2012) 34: 863-870.
  66. Hasniza ZH,Amy Tan LW Rokiah P, Che ZS, Riyanto TW. Factors influencing utilization of different types of sulphonylureas amongst type 2 diabetes patients. Lat. Am. J. Pharm. 29 (6):1044-8 (2010)
  67. Huri HZ, Lian GTP , Hussain S, Pendek R, Widodo RT. A survey amongst Complementary Alternative Medicine (CAM) users with type 2 diabetes. International Journal of Diabetes and Metabolism, Vol 17 No.1 April 2009:9-15
  68. Zaman Huri H, Foong G, Pendek R, Teguh Widodo R .Different characteristics of diabetic ketoacidosis between type 1 and type 2 diabetes patients in Malaysia. Asian Biomedicine 2009; 3 (2): 201-206
  69. Hasniza Zaman Huri, Lee Qiu Yi, Rokiah Pendek, Che Zuraini Sulaiman. Utilization of antiplatelet agents for primary and secondary prevention of cardiovascular disease amongst type 2 diabetics. Journal of Pharmacy Practice, Vol. 21, No. 4, 287-301 (2008).
  70. Hasniza Zaman Huri, Ong Chin Wen, Rokiah Pendek. Self- Monitoring Blood Glucose (SMBG) in type 2 diabetics in Malaysia. Asian Biomedicine, Vol 2 No.4 August 2008; 335-340.
Books
  1. Hasniza Zaman Huri, Chng Kiat Hui, Luqman Ibrahim (2017). Utilisation of Variable Rate Intravenous Insulin Infusion. Lambert Academic Publishing. Germany
  2. Bashar Mudhaffar Abdullah, Hasniza Zaman Huri, Emad Yousif. Biolubricant Base Oil Synthesis and Its Application: Pharmaceutical and Industrial Applications Based on Enviromental Friendly. Lambert Academic Publishing, Germany 2015.
  3. Bashar Mudhaffar Abdullah, Hasniza Zaman Huri, Nany Hairunisa. Hydrolysis, Separation and Purification of Fatty Acids for Bioproducts. Lambert Academic Publishing, Germany 2015.
  4. PT Thomas, Asrul Akmal Shafie, Chua Siew Siang, Mohamed Azmi Ahmad Hassali, Mohamad Haniki Nik Mohamed, Hasniza Zaman Huri, Lim Chin Choon, Chua Gin Nie & Yip Sook Ying 2012. Training Manual for Pharmacists for Management of Obesity and Overweight. Malaysia Academy of Pharmacy & Malaysian Pharmaceutical Society.
Chapter in Books
  1. Hasniza Zaman Huri (2012). Dyslipidemia and Type 2 Diabetes Mellitus: Implications and Role of Antiplatelet Agents in Primary Prevention of Cardiovascular Disease, Dyslipidemia - From Prevention to Treatment, Roya Kelishadi (Ed.), ISBN: 978-953-307-904-2, InTech.
  2. Zaman Huri, H. 2011. Dyslipidemia and type 2 diabetes mellitus: Implications and role of antiplatelet agents in primary prevention of cardiovascular diseases. Dlm. Dyslipidemia (in press): In Tech Publisher
Article in Proceeding
  1. Hasniza ZH, Noorasyikin S, Reena R, Samsinah HH. Pharmacy Programme and Clinical Pharmacy Teaching in the University of Malaya, 2006. International Conference on Clinical Pharmacy Education, Japan
Other Publications
  1. Hassanein, MM; Huri, HZ; Abduelkarem, AR. Determinants of serum vitamin D and its metabolites and the reflection on vitamin D status in postmenopausal women: A systematic review - Standard
  2. Sangeetha Perumalsamy, Hasniza Zaman Huri, Wan Azman Wan Ahmad. Association of YKL-40 Encoding Gene CHI3L1 rs946263 with Insulin Resistance and Severity of Coronary Artery Disease in Type 2 Diabetes Mellitus Patients. Metabolism (Clinical & Experimental) 0053 | VOLUME 116, SUPPLEMENT , 154520, MARCH 01, 2021. DOI: https://doi.org/10.1016/j.metabol.2020.154520 - Extended Abstract
  3. Suresh Rajakumar, Noorasyikin Shamsuddin, Dr Hasniza Zaman Nuri. Effectiveness of mRNA and recombinant adenovirus vector vaccine against different variants of COVID-19: a systematic review and meta-analysis. PROSPERO 2021 CRD42021269369 Available from: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021269369 - Mass Media(newspaper,radio,tv,popular Magazine)
  4. Tee Khim Boon, Hasniza Zaman Huri, Najihah Mohd Hashim, Luqman Ibrahim, Mohd Zuwairi Saiman Zaril Harza Zakaria, Kasful Asra Sakika, Syaza Fatnin Hisham, Azwa Mansor. Pharmacometabolomics of Meformin Demonstrated Insulin Sensitivity Related Pathways at Peak Plasma Concentration on Healthy Volunteers Preliminary Results. Metabolism (Clinical & Experimental) 0069 | VOLUME 116, SUPPLEMENT , 154536, MARCH 01, 2021. DOI: https://doi.org/10.1016/j.metabol.2020.154536 - Extended Abstract
  5. NAVIN K. LOGANADAN, HASNIZA ZAMAN HURI, SHIREENE R. VETHAKKAN, ZANARIAH HUSSEIN. Association of rs5219 KCNJ11 Gene Polymorphism with Pancreatic Beta-Cell Function, Insulin Resistance, and Glycemic Control of Sulfonylurea-treated Malaysian Type 2 Diabetes Patients. Diabetes (American Diabetes Association) 2016: A428 - Extended Abstract
  6. Jazlina Liza Jamaluddin, Hasniza Zaman Huri, Shireene Ratna Vethakkan, Norlaila Mustafa. The association of WFS1 gene polymorphisms with the DPP-4 inhibitors treatment response in type 2 diabetes.J Diab Metab 6: 10. - Extended Abstract
  7. Maryam Abbaspour Babaei, Hasniza Zaman Huri, Behnam Kamalidehghan. Compound 2,2'-Oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea Costalis induces apoptosis through activation of intrinsic, extrinsic and NF- B signaling pathways on human prostate cancer PC3 cells in vitro - Extended Abstract
  8. Navin Kumar Loganadan, Hasniza Zaman Huri, Shireene Ratna Vethakkan, Zanariah Hussein. Association Between Pancreatic Beta Cell Function and Glycemic Control of Type 2 Diabetes Patients on Maximal Sulphonylurea Therapy. Journal of the ASEAN Federation of Endocrine Societies 2015. 30 (2): 101. - Extended Abstract
  9. Hasniza Zaman Huri. Continuing Professional Development (CPD): Management of the Diabetic Foot (pg 31-38). Pharmacy Today (Malaysia) - Pharmacy Practice. December 2014. Published by MIMS (Hong Kong) Limited, Asia - recognised by Academy of Pharmacy, Malaysia. - Mass Media(newspaper,radio,tv,popular Magazine)
  10. Hasniza Zaman Huri. Continuing Professional Development (CPD): Managing Benign Prostatic Hyperplasia. Pharmacy Today (Malaysia) - Pharmacy Practice. December 2013. Published by MIMS (Hong Kong) Limited, Asia - recognised by Academy of Pharmacy, Malaysia. - Mass Media(newspaper,radio,tv,popular Magazine)
  11. Hasniza Zaman Huri. Continuing Professional Development (CPD): Managing Erectile Dysfunction. Pharmacy Today (Malaysia) - Clinical Pharmacy. April 2013: 21-22. Published by MIMS Medica Pacific Limited,Asia - recognised by Academy of Pharmacy, Malaysia. - Mass Media(newspaper,radio,tv,popular Magazine)
  12. Huri HZ, Makmor-Bakry M, Hashim R, Mustafa N, Wan Ngah WZ. Predictors for type 2 diabetes mellitus duringsevere/acute hyperglycemic phase. Abstract; 1st APCEEBM. - Extended Abstract
  13. H. Zaman Huri M. Makmor-Bakry, R. Hashim, N. Mustafa and WZ. Wan Ngah.Optimizing glycemic control during severe/acute hyperglycemic phase in type 2 diabetes patients: From predictors to a new approach. Abstract Book, Diabetes Asia 2011 Conference: 48 - Extended Abstract
  14. Riyanto Teguh Widodo, Hasniza Zaman Huri. (2008). Saliva Stimulating Tablets. 17th International Invention Innovation Industrial Design & Technology Exhibition 2008, KL-Malaysia 19-21 May 2008 - Extended Abstract
  15. Hasniza Zaman Huri, Ong Chin Wen, Rokiah Pendek \"A survey about Self Monitoring Bloog Glucose amongst type 2 diabetes outpatients\", 2007, 14th Congress of ASEAN Federation of Endocrine Societies (AFES) 2007, - Extended Abstract
  16. Riyanto Teguh Widodo, Samsinah Haji Hussain, Mohd Amin Jalaluddin, Hasniza Zaman Huri. Multipurpose liquid artificial saliva formulations. 2007. SMIDEX - Extended Abstract

RESEARCH PROJECT

National
  1. 2024 - 2027, UNIVERSITI MALAYA RESEARCH EXCELLENCE GRANT (UMREG)
    Unravelling the Pharmacogenetics of SGLT-2 Inhibitors: Towards Precision Medicine for Cardioprotection in Type 2 Diabetes Mellitus ( Co-Researcher)
  2. 2024 - 2027, Fundamental Research Grant Scheme (FRGS)
    Targeting Lipogenic Pathway In T2dm Patients With Cardiovascular Disease: Unravelling The Cardio-protective Mechanism Of Sglt2-inhibitor On Epicardial Fat Thickness Via Multi-omics Approach ( Principal Investigator(PI))
  3. 2024 - 2027, UNIVERSITI MALAYA RESEARCH EXCELLENCE GRANT (UMREG)
    Transforming Breast Cancer Treatment With 3d?needle Technology ( Co-Researcher)
  4. 2024 - 2026, Fundamental Research Grant Scheme (FRGS)
    Investigating In-vitro Neuroprotective Effects And In-vivo Pharmacokinetics Properties Of Intranasally Administered 3-(4-phenylbutoxy) Xanthone Lipid Nanocarriers. ( Co-Researcher)
  5. 2023 - 2025, Bantuan Khas Penyelidikan (BKP Special)
    Enhancing Pediatric Care In Malaysia: Introducing The First Electronic Clinical Decision Support For Health Professional ( Co-Researcher)
  6. 2023 - 2025, UM International Collaboration Grant
    Investigating The Role Of Genetic Polymorphisms Of Ugt1a9 On Pharmacokinetics Of Mycophenolic Acid In Renal Transplant Patients_ ( Co-Researcher)
  7. 2023 - 2025, Bantuan Khas Penyelidikan (BKP Special)
    Web-based Decision Aid For Pharmacological Management Major Depressive Disorder Patients: Feasibility And Efficacy Testing ( Co-Researcher)
  8. 2022 - 2024, KW PNC(JIM)
    Pharmacokinetics-pharmacometabolomics Profiling Of Registered Andographis Paniculata ( Principal Investigator(PI))
  9. 2019 - 2022, Others MOHE - Top 100 (IIRG)-FNW
    A Phase 1 Clinical Trial On Healthy Volunteers To Assess The Clinical Safety Of Andrographis Paniculata ( Principal Investigator(PI))
  10. 2019 - 2022, Others MOHE - Top 100 (IIRG)-FNW
    Metabolomics-driven Pharmaceutical Assessment Of Andrographis Paniculata (hempedu Bumi) As Antidiabetic Treatment ( Co-Researcher)
  11. 2019 - 2022, Others MOHE - Top 100 (IIRG)-FNW
    Pharmacokinetics Profile Of Andrographis Paniculata In Healthy Volunteer ( Principal Investigator(PI))
  12. 2019 - 2022, Others MOHE - Top 100 (IIRG)-IISS
    Graphene Based Human Breath Analyzing Sensors For Early Detaction Of Diabetes ( Co-Researcher)
  13. 2019 - 2022, Others MOHE - Top 100 (IIRG)-FNW
    A Phase 1 Clinical Trial On Healthy Volunteers To Assess The Clinical Safety Of Andrographis Paniculata ( Principal Investigator(PI))
  14. 2016 - 2019, Fundamental Research Grant Scheme (FRGS)
    Association Of Clinical And Genetic Markers With Erythropoietin Deficiency Anemia And Erythropoietin Stimulating Agents Treatment Response In Pre-dialysis Chronic Kidney Disease ( Principal Investigator(PI))
  15. 2016 - 2019, Postgraduate Research Grant (PPP) - Research
    Genetic Polymorphisms Associated With Insulin Resistance And Atherosclerosis In Type 2 Diabetes Mellitus Patients With Coronary Artery Disease. ( Principal Investigator(PI))
  16. 2014 - 2017, Geran Penyelidikan Universiti Malaya (UMRG Programme) - HTM (Wellness)
    Clinical And Genetic Predictors For Sulphonylurea Response In Malaysian Type 2 Diabeted Patients ( Principal Investigator(PI))
  17. 2014 - 2017, Postgraduate Research Grant (PPP) - Research
    CLINICAL AND GENETIC PREDICTORS FOR SULPHONYLUREA RESPONSE IN MALAYSIAN TYPE 2 DIABETES PATIENTS ( Principal Investigator(PI))
  18. 2015 - 2017, Geran Penyelidikan Universiti Malaya (UMRG) - AFR (Frontier Science)
    Investigating the role of miR-548m in epithelial-mesenchymal transition of cancer metastasis ( Co-Researcher)
  19. 2015 - 2017, Postgraduate Research Grant (PPP) - Research
    Targeting The Human Prostate Cancer Stem Cells (pc3) Using Natural Compound From Litsea Costalis: A Novel Strategy To Overcome The Drug Resistant Aggresive Breast Tumors ( Principal Investigator(PI))
  20. 2013 - 2015, Postgraduate Research Grant (PPP) - Research
    Genetic Markers Of Oral Incretin-Based Therapy Response In Type 2 Diabetes Mellitus ( Principal Investigator(PI))
  21. 2012 - 2015, MOSTI-Science Fund
    Impact Of Pax4 Genes Mutation On Sitagliptin Treatment Response In Type 2 Diabetes Mellitus Patients ( Principal Investigator(PI))
  22. 2012 - 2014, Geran Penyelidikan Universiti Malaya (UMRG) - HTM (Wellness)
    Clinical And Genetic Markers Of The Dpp Iv Inhibitors Treatment Response In Type 2 Diabetes Mellitus Patients ( Principal Investigator(PI))
  23. 2021 - 2023, Department of Medicine, University Malaya
    Exploring the role of SGLT-2 inhibition on epicardial adipose tissue (EAT) in type 2 diabetic patients with coronary artery disease. ( Co-Researcher)
  24. 2019 - 2022, Fundamental Research Grant Scheme (FRGS)
    Metabolic mechanism of inter-tissue crosstalk for excess nutrient flux in the biofluids of Type 2 Diabetes (T2D) individuals using an integrated multi-omics approach ( Consultant)
  25. 2020 - 2022, Private Funding
    Diabetes and Cardiometabolic Research ( Consultant)
  26. 2013 - 2015, Fundamental Research Grant Scheme (FRGS)
    Metabolic Mechanism of Reactive Oxygen Species induced Inflammation in Type 2 Diabetes ( Consultant)
  27. 2014 - 2015, Geran Penyelidikan Universiti Malaya (UMRG)
    CLINICAL AND GENETIC PREDICTORS FOR SULPHONYLUREA RESPONSE IN MALAYSIAN TYPE 2 DIABETES PATIENTS ( Principal Investigator(PI))
  28. 2012 - 2014, Geran Penyelidikan Universiti Malaya (UMRG)
    Clinical and genetic markers of DPPIV inhibitors treatment response in type 2 diabetes mellitus patients ( Principal Investigator(PI))
  29. 2012 - 2014, Postgraduate Research Grant(PPP)
    Genetic Markers of Oral Incretin-Based Therapy Response in Type 2 Diabetes Mellitus ( Principal Investigator(PI))
  30. 2006 - 2009, Fundamental Research Grant Scheme (FRGS)
    Saliva stimulating tablets formulations ( Consultant)
  31. 2008
    A STUDY OF ANTIHYPERTENSIVE USE IN DIABETICS
  32. 2008
    A STUDY ON THE USE OF SLIDING SCALE INSULIN
  33. 2008
    COMPLEMENTARY AND ALTERNATIVE MEDICINE USE AMONGST ADULT DIABETICS
  34. 2008
    A STUDY OF UTILIZATION OF ANTIPLATELET IN DIABETICS
  35. 2006 - 2007, none
    Utilization of antiplatelet for prevention of cardiovascular disease in diabetes patients ( Principal Investigator(PI))
  36. 2006 - 2007, none
    Characteristics of diabetes ketoacidosis (DKA) among type 2 diabetes patients ( Principal Investigator(PI))
  37. 2006 - 2007, none
    The use of self monitoring of blood glucose (SMBG) among type 2 diabete patients ( Principal Investigator(PI))
  38. 2006 - 2007, none
    Use of sulphonylureas in type 2 diabetes patients ( Principal Investigator(PI))
  39. 2005 - 2006
    A STUDY OF DIABETIC KETOACIDOSIS (DKA) IN ADULT PATIENTS WITH DIABETES MELLITUS
  40. 2005 - 2006, none
    Use of Complementary alternative medicines (CAMs) for type 2 diabetes patients ( Principal Investigator(PI))
  41. 2005 - 2006, none
    The use of antihypertensive agents among diabetes patients ( Principal Investigator(PI))
Private
  1. 2024 - 2027, Private Funding
    "health Intervention Programme And Public Perception In The Management Of Non-communicable Diseases (ncds) In Community Pharmacy In Malaysia " ( Principal Investigator(PI))
  2. 2022 - 2025, Private Funding
    Perception, Adherence, Clinical, Economical And Health-related Quality Of Life Outcomes Of Careaide App Usage In Chronic Diseases ( Co-Researcher)
  3. 2022 - 2024, Private Funding
    Pharmacokinetics-pharmacometabolomics Profiling Of Registered Andrographis Paniculata ( Principal Investigator(PI))
  4. 2020 - 2022, BOEHRINGER INGELHEIM (MALAYSIA) SDN. BHD.
    Exploring the role of SGLT-2 inhibition on epicardial adipose tissue (EAT) in type 2 diabetic patients with coronary artery disease. ( Co-Researcher)
International
  1. 2023 - 2025, International Funding
    Open, Randomized, Parallel Group Study To Assess Efficacy, Safety, And Tolerability Of Repeat Doses Of Vaginal Hyaluronic Gel In Pre- And Post-menopausal Female. ( Co-Researcher)
  2. 2022 - 2024, International Funding
    Effect Of Slc22a1 Gene Polymorphisms On Glycemic Control And Metformin Intolerance In Type 2 Diabetes Patients At St Paul's Hospital And Zewuditu Memorial Hospital, Addis Ababa, Ethiopia ( Principal Investigator(PI))
  3. 2019 - 2021, Impact Oriented Interdisclipinary Research Grant (IIRG)
    Pharmacometabolomics of Registered Andrographis Paniculata in Plasma and Urine ( Programme Leader)
  4. 2012 - 2014, ScienceFund
    Impact of PAX4 genes mutation on sitagliptin treatment response in type 2 diabetes mellitus patients. ( Principal Investigator(PI))
University
  1. 2024 - 2026, Bantuan Khas Penyelidikan (BKP Special)
    Personalized Medicine of Mycophenolic Acid Through Integration of Pharmacogenomic and Pharmacometrics Approaches in Renal Transplant ( Co-Researcher)

CONSULTANCY PROJECT

  • Rhazes Telepharmacy, RHAZES CONSULTANCY SERVICES SDN BHD, Professional Consultant (Ir., Ar., Sr., Ts., dsbnya)
    06 Oct 2023 - 22 Oct 2026 (International)
  • Improvement and Proof Reading of Manuscript, Novugen Pharma (Malaysia) Sdn Bhd, Consultant
    28 Mar 2022 - 28 Apr 2022 (International)
  • Editor for Mims Gateway Website, MIMS Medica Sdn Bhd
    01 Jan 2012 - 01 Jan 2015 (National)

PAPER PRESENTED

PLENARY SPEAKER
  1. Global Career opportunities for Pharma Graduates, International Conference CAPCON'24, Dr Moopen's College of Pharmacy, (International) (23 Nov 2024 - 23 Nov 2024)
  2. Synergies in Digital Healthcare : Bridging Pharmacy Research and Patient Wellness, 7th International Conference on Advance Pharmacy and Pharmaceutical Sciences (ICAPPS), Faculty of Pharmacy, Universitas Indonesia (International) (31 Oct 2024 - 02 Nov 2024)
  3. Precision Medicine: The Way Forward, V International Scientific and Practical Conference The Current State of the Pharmaceutical Industry: Problems and Prospects ., Tashkent Pharmaceutical Institute (International) (17 Oct 2024 - 17 Oct 2024)
  4. Strengthening Health Professionals through Religiosity and Collaboration for Global Health, Third International Conference on Health Sciences (ICHS), University Syarif Hidayatullah Jakarta (International) (08 Aug 2024 - 09 Aug 2024)
  5. Unlocking the Vital Role of Pharmacists in Clinical Trial: Ensuring Safety and Patient Care, Malaysian Pharmacists Society National Pharmacists Convention 2024 (MPS NPC), Malaysian Pharmacists Society (MPS) (International) (26 Jul 2024 - 28 Jul 2024)
  6. Pharmaceutical Care in COVID 19: What a Clinical Pharmacist Can Do to Alleviate the DIsease Burden ?, 7th International Conference on Pharmacy and Advanced Pharmaceutical Sciences (ICPAPS 2021) in collaboration with the 12th Annual Conference of the Indonesian Society for Cancer Chemoprevention (ISCC 2021), Universitas Gadjah Mada (UGM) (International) (03 Nov 2021 - 03 Nov 2021)
INVITED SPEAKER
  1. Precision Medicine: The Way Forward, International Scientific and Practical Conference Genetic Technologies for Biology and Medicine, Belgorod State University (International) (18 Nov 2024 - 19 Nov 2024)
  2. Diabetic Infection: Risk, Treatment and Prevention, International Guest Lecture, Esa Unggul University, Jakarta, Indonesia (International) (14 Oct 2024 - 14 Oct 2024)
  3. Precision Medicine in Metabolic Diseases The Way Forward, INTERNATIONAL PHARMACY AND PHARMACEUTICAL SCIENCE CONFERENCE 2024 (IPPSC 2024), International Medical University, Bukit Jalil, Kuala Lumpur, Malaysia. (International) (31 Jul 2024 - 31 Jul 2024)
  4. Precision Medicine: One Size Does Not Fit All !, 1st Endocrine Pharmacy Conference JKWPKL&P 2023, Jabatan Kesihatan Wilayah Persekutuan Kuala Lumpur dan Putrajaya (National) (08 Oct 2023 - 08 Oct 2023)
  5. Precision Medicine in Diabetes Mellitus, INTERNATIONAL CONGRESS OF PATHOLOGY AND LABORATORY MEDICINE (ICPALM 2023) External, INTERNATIONAL CONGRESS OF PATHOLOGY AND LABORATORY MEDICINE (ICPALM 2023) External (International) (21 Sep 2023 - 21 Sep 2023)
  6. Navigating Clinical Trials in Asia: A New Landscape and Horizon, The 2nd ARISE-PMDA Joint Symposium for Asian Clinical Trials: How to collaborate as one Asia, NCGM, PMDA Japan (International) (20 Jul 2023 - 20 Jul 2023)
  7. Precision Medicine in Management of Metabolic Diseases, 1st INTERNATIONAL SYMPOSIUM OF PHARMACY RESEARCH (IMPRES), Faculty of Pharmacy, Universiti Malaya (International) (09 Dec 2022 - 09 Dec 2022)
  8. Diabetes Mellitus and COVID-19 Infection, Online Symposium INTI International University, INTI International University (National) (02 Nov 2022 - 02 Nov 2022)
  9. Precision Medicine - The Way Forward, INTERNATIONAL e-CONFERENCE ON ADVANCES IN PHARMACEUTICAL AND HEALTH SCIENCES, GH Raisoni University (International) (25 Mar 2022 - 26 Mar 2022)
  10. Masking obstacles of scientist mothers: Silence epidemic within a pandemic, USM Pharmacy Webinar, Science University of Malaysia (National) (11 Jul 2020 - 11 Jul 2020)
  11. Bridging the Gap between Laboratories and Market, Biosimilar Carnival 2018, Innobioventures and MESTECC (International) (29 Oct 2018 - 30 Oct 2018)
  12. Landscape and Perspective of Regenerative Medicine Clinical Trials, Innovation Forum: Entrepreneurship in Health Care, Innovation Forum Global and University Malaya (International) (21 Sep 2018 - 22 Sep 2018)
  13. Clinical Investigation Centre (CIC), Science Cafe -FOM Shared Research Facility, Faculty of Medicine (University) (14 Aug 2018 - 14 Aug 2018)
  14. Good Clinical Practice (GCP), Pre-Clinical and Phase I Clinical Trials in the Cell-Based Therapy and Drug Development, NOCERAL (National) (26 Feb 2018 - 26 Feb 2018)
EVENT ORGANISER
  1. Introduction to CIC , CIC Clinical Trial Attachment Program, CIC (National) (23 Jan 2019 - 24 Jan 2019)
  2. GCP Workshop, GCP Workshop December 2018, Clinical Investigation Centre (CIC) (National) (04 Dec 2018 - 06 Dec 2018)
  3. GCP Workshop, GCP Workshop October 2018, Clinical Investigation Centre (CIC) (National) (23 Oct 2018 - 25 Oct 2018)
  4. GCP Workshop, GCP Workshop July 2018, Clinical Investigation Centre (CIC) (National) (03 Jul 2018 - 05 Jul 2018)
  5. GCP workshop, GCP workshop March 2018, Clinical Investigation Centre (CIC) (National) (20 Mar 2018 - 22 Mar 2018)
  6. Harmonisation and Synchronisation of Undergraduate Pharmacy Curriculum, Pharmacy Education Symposium 2015, Department of Pharmacy, Faculty of Medicine, University of Malaya (National) (16 Oct 2015 - 17 Oct 2015)
  7. Pharmacy: Leading & Managing Change, 11th MPS-PSC 2012, Department of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur,MPS Malaysia, Pharmaceutical Services Division, MOH, Malaysia. (International) (31 Oct 2012 - 02 Nov 2012)
ORAL PRESENTER
  1. Optimizing glycemic control in type 2 diabetes mellitus patients during severe/acute hyperglycemic phase: From predictors to a new approach, Diabetes Asia 2011 (International) (06 Oct 2011 - 09 Oct 2011)
  2. Optimizing the glycemic control in type 2 diabetes patients during severe/acute hyperglycemic phase: From predictors to a new approach, UKM Research Day, Universiti Kebangsaan Malaysia (University) (20 Jul 2011 - 20 Jul 2011)
POSTER PRESENTER
  1. Pharmacometabolomics of Meformin demonstrated insulin sensitivity related pathways at peak plasma concentration on healthy volunteers Preliminary results, 18th World Congress Insulin Resistance Diabetes & Cardiovascular Disease (WCIRDC), The Metabolic Institute of America (TMIOA) (International) (03 Dec 2020 - 06 Dec 2020)
  2. Association of YKL-40 Encoding Gene CHI3L1 rs946263 with Insulin Resistance and Severity of Coronary Artery Disease in Type 2 Diabetes Mellitus Patients, 18th World Congress of Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC) , The Metabolic Institute of America (TMIOA) (International) (03 Dec 2020 - 06 Dec 2020)
  3. THE IMPACT OF ACADEMIC DETAILING ON ENHANCING STATIN THERAPY PRESCRIBING IN MALAYSIAN PRIMARY CARE SETTINGS: QUASI-EXPERIMENTAL DESIGN, ISPOR 23rd Annual International Meeting, ISPOR (International) (21 May 2018 - 21 May 2018)
  4. Navin Kumar Loganadan, Hasniza Zaman Huri, Shireene Ratna Vethakkan, Zanariah Hussein. Association Between Pancreatic Beta Cell Function and Glycemic Control of Type 2 Diabetes Patients on Maximal Sulphonylurea Therapy. Journal of the ASEAN Federation of Endocrine Societies 2015. 30 (2): 101. , ASEAN Federation of Endocrine Societies (AFES) Congress, ASEAN Federation of Endocrine Societies (AFES) (International) (10 Dec 2015 - 13 Dec 2015)
  5. Natural Compound 2,2'-Oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea Costalis induces apoptosis through activation of intrinsic, extrinsic and NF- B signaling pathways on human prostate cancer PC3 cells in vitro, 12th MPS Pharmacy Scientific Conference 2015 (MPS-PSC 2015) , Malaysian Pharmaceutical Society (International) (13 Nov 2015 - 15 Nov 2015)
  6. The association of WFS1 gene polymorphisms with the DPP-4 inhibitors treatment response in type 2 diabetes, 8th Euro Global Diabetes Summit and Medicare Expo - November 03-05, 2015- Valencia, Spain (International) (03 Nov 2015 - 05 Nov 2015)
  7. Pathway Mechanism of Potential Genomic Markers of Dipeptidyl Peptidase-4 Inhibitor Treatment Response in Type 2 Diabetes, Golden Helix Symposium 2015 (International) (12 Mar 2015 - 13 Mar 2015)
  8. Impact of Single Nucleotide Polymorphisms(SNPs) of Type 2 Diabetes (T2D) Genes on Patients Response to Sulphonylurea Therapy, Golden Helix Symposium 2015 (International) (12 Mar 2015 - 13 Mar 2015)
  9. Association of Genetic Polymorphisms of Dipeptidyl Peptidase-4 with Metabolic Syndrome Parameters in Malaysian Subjects, Golden Helix Symposium 2015 (International) (12 Mar 2015 - 13 Mar 2015)
  10. Potential biomarkers of Insulin Resistance and Atherosclerosis among T2DM patients with Coronary Artery Disease, 12th International Congress on Obesity (International) (17 Mar 2014 - 20 Mar 2014)
  11. Demographic and Clinical Predictors for Insulin Resistance in Type 2 Diabetes Mellitus Patients During Severe/Acute Hyperglycemia Phase, 1st Asia Pacific Clinical Epidemiology and Evidence-Based Medicine Conference (International) (06 Jul 2012 - 08 Jul 2012)
  12. A survey about self monitoring of blood glucose amongst type 2 diabetes inpatients, 14th Congress of Asean Federation of Endocrine Societies (AFES), Asean Federation of Endocrine Societies (International) (30 Nov 2007 - 02 Dec 2007)
  13. Pharmacy Programme and Clinical Pharmacy Teaching in the University of Malaya, International Conference on Clinical Pharmacy Education; Tokyo, Japan (International) (02 Jun 2006 - 03 Jun 2006)
PRESENTER
  1. Association between abcc8 rs757110 (ser1369ala) gene polymorphism and sulphonylurea response in Malaysian type 2 diabetes patients, 77th FIP World Congress of Pharmacy and Pharmaceutical Sciences, International Pharmaceutical Federation (FIP) (International) (10 Sep 2017 - 14 Sep 2017)
  2. Abu Bakar, Mohamad Hafizi; Zaman Huri, Hasniza; Hairunisa, Nany. Alterations of cultured myotubes and fasting plasma metabolite profile related to mitochondrial dysfunction in Type 2 diabetes subjects, OCC World Congress 2017 and Annual SFRR-E Conference , OCC World Congress 2017 and Annual SFRR-E Conference  (International) (21 Jun 2017 - 23 Jun 2017)
  3. Genetic Polymorphisms in Uncontrolled Type 2 Diabetes Mellitus with Overweight and Obesity Patients, Monash Science Symposium 2016, Monash University Malaysia (International) (21 Nov 2016 - 23 Nov 2016)
  4. Glycemic Control Among Simvastatin User In Diabetic Patients With Oral Antidiabetic, Monash Science Symposium 2016, Monash University Malaysia (International) (21 Nov 2016 - 23 Nov 2016)
  5. Demographic and clinical predictors for type 2 diabetes patients during severe/acute hyperglycemic phase, 1st Asia Pacific Clinical Epidemiology and Evidence Based Medicine (International) (06 Jul 2012 - 08 Jul 2012)
KEYNOTE SPEAKER
  1. Pharmacokinetics-Pharmacometabolomics Driven Pharmacodynamics of Andrographis Paniculata, International Symposium for Pharmaceutical Sciences, National Yang-Ming Chiao-Tung University (International) (30 Nov 2024 - 30 Nov 2024)
  2. Precision Medicine - The Way Forward, 1st Esa Unggul-International Conference of Health Sciences (1st EUE-ICHS), Esa Unggul University, Jakarta Indonesia (International) (15 Oct 2024 - 16 Oct 2024)
  3. Unraveling Pharmacodynamics of Andographis Paniculata via Pharmacometabolomics Approach, the 2nd 'the Belt and Road' International Conference on Cooperation and Integration of Pharmaceutical Industry, Education and Application, China Pharmaceutical University (International) (16 May 2024 - 18 May 2024)
  4. New Pharmacological Interventions for the Prevention and Treatment of Obesity, FIP Digital Event 4 March 2024, The International Pharmaceutical Federation (FIP) (International) (04 Mar 2024 - 04 Mar 2024)
  5. Peran dari Dunia Pendidikan dalam Pertumbuhan Ekonomoi Masyarakat Indonesia dan Malaysia, Webinar Peran dari Dunia Pendidikan dalam Pertumbuhan Ekonomoi Masyarakat Indonesia dan Malaysia, Barisan Muda Wirausaha Indonesia (International) (29 Jul 2023 - 29 Jul 2023)
  6. Type 2 Diabetes: Transformation of Research in Clinical Pharmacy, International Conference on Health Innovation, Anwar Medika University Indonesia (International) (26 Jul 2023 - 27 Jul 2023)
  7. Precision Medicine - The Way Forward, 4th International Congress of Medical Sciences and Multidisciplinary Approaches, Guven Plus, ORP, GPGD (International) (26 Mar 2022 - 27 Mar 2022)
  8. Heart failure with type 2 diabetes: Prescribing patterns of antihyperglycemic agents and the association between glycemic control with ejection fraction, Webinar on Clinical Pharmacy and Clinical Research, Allied Academies (International) (16 Apr 2021 - 16 Apr 2021)

ACADEMIC/ PROF. SERVICES

Evaluation
  1. (2025) External Examiner for Phd Thesis, National, (External Examiner)
  2. (2025) External Assessor for Promotion Exercise, National, (External Assessor)
  3. (2024) External Assessor to Promotion of Associate Professor, International, (External Assessor)
  4. (2024) External Assessor for Promotion to Associate Professor, International, (External Assessor)
  5. (2024) External Examiner for a Phd Thesis, International, (External Examiner)
  6. (2024) External Examiner for a Phd Thesis, National, (External Examiner)
  7. (2024) External Examiner to Phd Thesis USM September 2024, National, (External Examiner)
  8. (2024) External Assessor for Academic Promotion, National, (External Assessor)
  9. (2024) Judge for Oral Presentation Pharmacy R&d Coneference 2014, International, (External Evaluator)
  10. (2024) Internal Examiner of Master Thesis (um), University, (Internal Examiner)
  11. (2024) External Examiner to Phd Thesis (usm), National, (External Examiner)
  12. (2024) IIUM -external Assessor for Promotion, National, (External Assessor)
  13. (2024) External Examiner to a Master Thesis (usm) June 2024, National, (External Examiner)
  14. (2024) External Assessor for Promotion to Professor, International, (External Evaluator)
  15. (2024) External Examiner to Phd Thesis UKM, National, (External Examiner)
  16. (2024) External Evaluator for Promotion to Associate Professor, International, (External Evaluator)
  17. (2024) External Examiner to a Master Candidate, National, (External Examiner)
  18. (2024) External Examiner to a Phd Candidate, International, (External Examiner)
  19. (2023) External Examiner for Phd Thesis, National, (External Examiner)
  20. (2023) External Assessor for Promotion to Professorship (king Saud University), International, (External Evaluator)
  21. (2023) Promotion to Professorship -king Saud University - Saudi Arabia, International, (External Evaluator)
  22. (2023) External Examiner for Phd Thesis, National, (External Examiner)
  23. (2023) External Examiner for a Phd Thesis, National, (External Examiner)
  24. (2023) External Examiner for Phd Thesis (ukm), National, (External Examiner)
  25. (2023) External Examiner to a Phd Thesis (cyberjaya University), National, (External Examiner)
  26. (2023) External Examiner for a Candidate of Doctor of Philosophy (uiam), National, (External Examiner)
  27. (2023) External Examiner Phd (ukm), National, (External Examiner)
  28. (2023) External Examiner to a Phd Thesis, National, (External Examiner)
  29. (2023) External Examiner to a Phd Thesis, National, (External Examiner)
  30. (2023) External Examiner for a Master Thesis (usm), National, (External Examiner)
  31. (2023) External Examiner to a Master Thesis (usm), National, (External Examiner)
  32. (2023) Reviewer for a Journal Listed in Wos, International, (Reviewer)
  33. (2023) External Examiner to a Phd Thesis USM, National, (External Examiner)
  34. (2023) External Examiner for Bachelor of Pharmacy (hons) Imu, National, (External Examiner)
  35. (2023) External Examiner for Bachelor of Pharmacy (hons), National, (External Assessor)
  36. (2022) International Jury for Malaysian Technology Expo (mte) 2022, International, (External Evaluator)
  37. (2022) Review An Article (june 2022), International, (Reviewer)
  38. (2022) Reviewer for a Manuscript (june 2022), International, (Reviewer)
  39. (2022) Review An Article (june 2022), International, (Reviewer)
  40. (2022) External Examiner for a Master Thesis, National, (External Examiner)
  41. (2022) Reviewer of An Article (june 2022), International, (Reviewer)
  42. (2022) External Examiner for a Phd Thesis (usm), National, (External Examiner)
  43. (2022) External Examiner for Bachelor of Pharmacy (honours) - Semester 6, National, (External Examiner)
  44. (2022) External Examiner for a Master of Medical Sciences Candidate, National, (External Examiner)
  45. (2022) Editorial Board for Panacea, University, (Reviewer)
  46. (2022) External Examiner to a Phd Student, National, (External Examiner)
  47. (2021) External Examiner to a Master of Science's Student (ukm), National, (External Examiner)
  48. (2021) External Examiner to a Master Student (unimas), National, (External Examiner)
  49. (2021) External Examiner - Master of Pharmacy Practice, National, (External Examiner)
  50. (2021) Review An Article, International, (Reviewer)
  51. (2021) External Examiner for a Master Thesis (usm), National, (External Examiner)
  52. (2021) Review a Journal Article (june 2021), International, (Reviewer)
  53. (2021) Judge for National Pharmacist Convention 2021, National, (External Evaluator)
  54. (2021) Jury Member for International Innovation Awards 2021, International, (External Evaluator)
  55. (2021) Reviewer of Manuscript (march 2021), International, (Reviewer)
  56. (2021) Review of An Article - World Journal of Diabetes, International, (Reviewer)
  57. (2021) Reviewer for Drug, Healthcare and Patient Safety (january 2021), International, (Reviewer)
  58. (2021) Reviewer for Journal of Diabetes and Clinical Practice, International, (Reviewer)
  59. (2021) Reviewer for Gene Reports (June 2021) , (Reviewer)
  60. (2021) Reviewer for European Journal of Clinical Investigation (WOS Indexed) - March 2021, (Reviewer)
  61. (2021) Reviewer for Drug, Healthcare and Patient Safety (January 2021), (Editor)
  62. (2021) Reviewer for Diabetes Research and Clinical Practice (ISI-indexed) - January 2021 , (Reviewer)
  63. (2021) Reviewer - World Journal of Diabetes (January 2021) - ISI-Indexed , (Reviewer)
  64. (2020) Reviewer for Canadian Journal of Diabetes (October 2020 ) -ISI-indexed , (Reviewer)
  65. (2020) External Examiner for Master in Pharmacy Practice (International Medical University), (External Examiner)
  66. (2020) Reviewer for Expert Review of Endocrinology & Metabolism (October 2020) , (Reviewer)
  67. (2020) Reviewer for Drug, Healthcare and Patient Safety (October 2020), (Reviewer)
  68. (2020) Reviewer for International Journal of Diabetes in Developing Countries (JDCC) -August 2020 (ISI-indexed) , (Reviewer)
  69. (2020) Reviewer - International Journal of Diabetes in Developing Countries (July 2020) , (Reviewer)
  70. (2020) Reviewer: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy (April 2020) -ISI-indexed, (Reviewer)
  71. (2020) Manuscript review -Risk Management and Healthcare Policy ( February 2020) , (Reviewer)
  72. (2020) Reviewer - Clinical Nutrition ESPEN (ISI-cited) February 2020 , (Reviewer)
  73. (2020) Reviewer - BMC Medical Genetics (January 2020) , (Reviewer)
  74. (2020) External Examiner for a Master's thesis , (External Examiner)
  75. (2020) Reviewer for Malaysian Journal of Medical Sciences , (Reviewer)
  76. (2019) Assessor for a phD application (July 2019), (Assessor for phD application)
  77. (2019) Reviewer - Clinical Nutrition ESPEN (June 2019) , (Reviewer)
  78. (2019) External Examiner for a pHD thesis - June 2019 , (External Examiner)
  79. (2019) Reviewer - Journal of Integrative Medicine (May 2019), (Reviewer)
  80. (2019) Reviewer - Journal of Clinical Pharmacy and Therapeutics - ISI-indexed (April 2019), (Reviewer)
  81. (2019) Oral and thesis examiner for MIC 4005 Research in Biomedical Science , (External Examiner)
  82. (2019) Reviewer - Primary Care Diabetes - ISI-indexed (March 2019), (Reviewer)
  83. (2019) Reviewer - PeerJ - ISI-indexed (March 2019), (Reviewer)
  84. (2019) Reviewer for Plos One (ISI-indexed) - March 2019 , (Reviewer)
  85. (2019) Reviewer - Primary Care Diabetes (ISI-indexed) - March 2019, (Reviewer)
  86. (2019) Reviewer for Primary Care Diabetes (ISI-Indexed) - February 2019 , (Reviewer)
  87. (2019) Reviewer, Indian Journal of Pharmaceutical Education and Research (ISI-indexed) -January 2019 , (Reviewer)
  88. (2019) Assessor for a Master Application (January 2019) , (Assessor)
  89. (2019) Reviewer; International Journal of Clinical Pharmacy (ISI-indexed) - January 2019, (Reviewer)
  90. (2018) External Examiner for Doctor of Pharmacy (PharmD) Program , (External Examiner)
  91. (2018) Reviewer - The Pharmacogenomics Journal, (Reviewer)
  92. (2018) Assessor for Candidature Defence for a Master Candidate (01.10.2018) , (Assessor)
  93. (2018) Reviewer - Journal of Diabetes (ISI-indexed journal) - June 2018 , (Reviewer)
  94. (2018) Reviewer - BMJ Open (ISI-cited) - February 2018 , (Reviewer)
  95. (2018) Reviewer for Clinical Immunology, Endocrine & Metabolic Drugs (April 2018), (Reviewer)
  96. (2018) Reviewer for Family Medicine and Community Health (April 2018), (Reviewer)
  97. (2018) Reviewer - BMC Endocrine Disorders (ISI-cited) - April 2018, (Reviewer)
  98. (2018) Reviewer - Biomarkers in Medicine (ISI-indexed) - March 2018 , (Reviewer)
  99. (2018) Reviewer- BMC Cardiovascular Disorders (ISI-indexed) - March 2018 , (Reviewer)
  100. (2018) Reviewer - Journal of Clinical Nursing (ISI-cited) - March 2018, (Reviewer)
  101. (2018) Reviewer - Current Diabetes Reviews (March 2018) , (Reviewer)
  102. (2018) Reviewer - Journal of Clinical Pharmacy & Therapeutics (February 2018) , (Reviewer)
  103. (2018) Evaluator for grant application, (Grant Application Evaluator)
  104. (2018) Assessor for Candidature Defence (February 2018), (Assessor)
  105. (2017) Reviewer - Brazilian Journal of Pharmaceutical Sciences - ISI cited (September 2017) , (Reviewer)
  106. (2017) Reviewer - Journal of Diabetes Investigation - ISI-indexed (February 2017) , (Reviewer)
  107. (2017) Reviewer - BMJ Open (ISI-indexed) - October 2017 , (Reviewer)
  108. (2017) Grant Evaluator - October 2017 , (Grant Evaluator)
  109. (2017) Reviewer - Plos One (ISI-indexed) - October 2017 , (Reviewer)
  110. (2017) Reviewer - Diabetic Medicine (ISI-indexed) - October 2017 , (Reviewer)
  111. (2017) Reviewer - Endocrinology, Diabetes and Metabolism Case Reports - ISI-indexed (January 2017) , (Reviewer)
  112. (2017) External Examiner for one student - Master of Clinical Pharmacy -CUCMS (September 2017) , (External Examiner)
  113. (2017) Grant Evaluator (July 2017), (Grant Evaluator)
  114. (2017) Reviewer for a manuscript-Genetic Testing and Molecular Biomarkers (ISI-Indexed) - June 2017 , (Reviewer)
  115. (2017) External examiner for one student- Master of Clinical Pharmacy (CUCMS) - March 2017, (External Examiner)
  116. (2017) Reviewer: BMC Research Notes (February 2017), (Reviewer)
  117. (2017) Reviewer - Brazilian Journal of Pharmaceutical Sciences - ISI cited (January 2017), (Reviewer)
  118. (2017) Candidature Defence for a Master Project - February 2017, (Internal Examiner)
  119. (2017) Reviewer: American Journal of Medicine and Medical Sciences (February 2017), (Reviewer)
  120. (2017) External Examiner for thesis evaluation for 2 students under the program of Bachelor of Pharmacy - CUCMS, (External Examiner)
  121. (2016) Reviewer; BMC Endocrinology (August 2016), (Reviewer)
  122. (2016) Evaluator for a Master project application (August 2016), (Evaluator)
  123. (2016) Expert Panel for Development of Clinical Pharmacy Specialist in Malaysia - Pharmaceutical Services Divisions, Ministry of Health, Malaysia., (Expert Panel)
  124. (2016) Reviewer; American Journal of Medicine and Medical Sciences (July 2016), (Reviewer)
  125. (2016) Reviewer; Journal of Pediatric Endocrinology and Metabolism (JPEM) - ISI (May 2016), (Reviewer)
  126. (2016) Reviewer; British Journal of Pharmaceutical Research (May 2016), (Reviewer)
  127. (2016) Reviewer; International Journal of Diabetes Research (May 2016), (Reviewer)
  128. (2016) Reviewer; BMC Complementary and Alternative Medicine (ISI)- April 2016, (Reviewer)
  129. (2016) Reviewer; BMC Complementary and Alternative Medicine (ISI) - March 2016 , (Reviewer)
  130. (2016) Reviewer; BMC Cardiovascular Disorders (ISI) - February 2016 , (Reviewer)
  131. (2016) Reviewer; Canadian Journal of Diabetes (ISI) - February 2016 , (Reviewer)
  132. (2016) Reviewer; BMC Complementary and Alternative Medicine (ISI)-January 2016 , (Reviewer)
  133. (2016) Reviewer; Postgraduate Medicine (ISI) - March 2016 , (Reviewer)
  134. (2016) Reviewer; International Journal of Applied Psychology (February 2016), (Reviewer)
  135. (2016) Reviewer; British Journal of Medicine and Medical Research (February 2016), (Reviewer)
  136. (2016) Reviewer; British Journal of Medicine and Medical Research (January 2016), (Reviewer)
  137. (2016) Examiner for a Master thesis (January 2016) , (Internal Examiner)
  138. (2015) ph.D application, (Evaluator)
  139. (2015) Moderator for a Master Proposal Presentation, (Moderator)
  140. (2015) Evaluator for a ph.D application, (Evaluator)
  141. (2015) Examiner for a Master Project (November 2015), (Examiner)
  142. (2015) Ph.D proposal presentation, (Moderator)
  143. (2015) Evaluator for a ph.D application, (Evaluator)
  144. (2015) Change of ph.D research title, (Evaluator)
  145. (2015) Reviewer; American Journal of Medicine and Medical Sciences (September 2015), (Reviewer)
  146. (2015) External evaluator for a grant application (International), (Evaluator for grant application)
  147. (2015) External Examiner for a Master thesis - September 2015, (External Examiner)
  148. (2015) Internal Examiner for a phD project - July 2015, (Internal Examiner)
  149. (2015) Assessor for Candidature Defence(Master) MMedSc - 16 April 2015, (Examiner)
  150. (2015) Moderator for MedSc proposal presentation - 28.05.2015, (Moderator)
  151. (2015) Reviewer; American Journal of Medicine and Medical Sciences (June 2015) , (Reviewer)
  152. (2015) Reviewer; International Journal of Diabetes Research (May 2015), (Reviewer)
  153. (2015) Reviewer; International Journal of Prevention and Treatment (April 2015), (Reviewer)
  154. (2015) Reviewer; Journal of American Pharmacists Association (ISI) - February 2015 , (Reviewer)
  155. (2015) Reviewer; International Journal of Diabetes Research (April 2015), (Reviewer)
  156. (2015) Reviewer; Clinical Drug Investigation (ISI) - October 2015 , (Reviewer)
  157. (2015) Reviewer; Plos One (ISI) - November 2015 , (Reviewer)
  158. (2015) Reviewer; Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy (March 2015), (Reviewer)
  159. (2015) Reviewer; BMC Research Notes (March 2014), (Reviewer)
  160. (2015) Proposal for a Master Candidate (February 2015) , (Evaluation Committee)
  161. (2015) Proposal for a phD candidate (February 2015), (Evaluation Committee)
  162. (2015) Reviewer; International Journal of Diabetes Research (February 2015), (Reviewer)
  163. (2015) Reviewer; International Journal of Diabetes Research (January 2015), (Reviewer)
  164. (2015) Reviewer; Malaysian Journal of Medical Sciences (January 2015), (Reviewer)
  165. (2014) Reviewer; American Journal of Medicine and Medical Sciences (December 2014), (Reviewer)
  166. (2014) Reviewer; International Journal of Statistics and Applications (November 2014), (Reviewer)
  167. (2014) Reviewer; THE World Journal of Diabetes (August 2014), (Reviewer)
  168. (2014) Assessor for Master Candidature Defence (17 December 2014) , (Assessor)
  169. (2014) Reviewer; World Journal of Gastroenterology (April 2014), (Reviewer)
  170. (2014) Reviewer; Indian Journal of Pharmaceutical Education and Research (ISI) - August 2014 , (Reviewer)
  171. (2014) Reviewer; BMJ Case Report (ISI) - September 2014 , (Reviewer)
  172. (2014) Reviewer; Cardiovascular Diabetology (ISI) - July 2014 , (Reviewer)
  173. (2014) Reviewer; Indian Journal of Pharmaceutical Education and Research (ISI) - May 2014 , (Reviewer)
  174. (2014) Reviewer; BMJ Open (ISI) - July 2014 , (Reviewer)
  175. (2014) Reviewer; Indian Journal of Pharmaceutical Education and Research (ISI) - April 2014 , (Reviewer)
  176. (2014) Reviewer; Journal of Diabetes and Metabolism, OMICS Publishing Group (February 2014) , (Reviewer)
  177. (2014) Reviewer; Journal of Endocrinology and Diabetes Mellitus (February 2014), (Reviewer)
  178. (2014) Reviewer; Public Health Research (January 2014), (Reviewer)
  179. (2014) External examiner for a thesis (Master of Clinical Pharmacy); January 2014, (External Examiner)
  180. (2013) Reviewer; International Journal of Diabetes Research (October 2013), (Reviewer)
  181. (2013) Reviewer; British Journal of Pharmaceutical Research (September 2013) , (Reviewer)
  182. (2013) Assessor for phD Candidature Defence (24 October 2013), (Assessor )
  183. (2013) External examiner for a thesis (Master of Clinical Pharmacy); September 2013 , (External Examiner)
  184. (2013) Reviewer; Journal of Endocrinology and Diabetes Mellitus (September 2013), (Reviewer)
  185. (2013) Reviewer; International Journal of Diabetes Research (August 2013) , (Reviewer)
  186. (2013) Reviewer; International Journal of Surgical Research (July 2013), (Reviewer)
  187. (2013) Reviewer; Clinical Practice (July 2013), (Reviewer)
  188. (2013) Reviewer: Journal of Obstetrics and Gynecology (July 2013), (Reviewer)
  189. (2013) Reviewer; International Journal of Diabetes Research (30 May 2013), (Reviewer)
  190. (2013) Reviewer; Journal of Cancer Science & Therapy (February 2013) , (Reviewer)
  191. (2013) Reviewer; Clinical Practice (May 2013) , (Reviewer)
  192. (2013) Reviewer; Frontiers in Science (May 2013), (Reviewer)
  193. (2013) Reviewer; International Journal of Diabetes Research (April 2013) , (Reviewer)
  194. (2013) Reviewer; American Journal of Medicine and Medical Sciences (May 2013), (Reviewer)
  195. (2013) Reviewer; Indian Journal of Pharmaceutical Education and Research (ISI)- September 2013 , (Reviewer)
  196. (2013) External examiner for a thesis (Aini Athirah Shabudin) (Bachelor of Pharmacy); Disember 2013, (External Examiner)
  197. (2013) External examiner for a thesis (Latha Devi Sukumaran) (Bachelor of Pharmacy); Disember 2013, (External Examiner)
  198. (2012) Editorial Board of Mintage Journal of Pharmaceutical & Medical Sciences (2012), (Editorial Board)
  199. (2012) Clinical Practice (reviewer; 2012-2014) , (Reviewer)
  200. (2012) Journal of Health Sciences (reviewer; 2012-2014) , (Reviewer)
  201. (2012) International Journal of Diabetes Research (reviewer; 2012-2014) , (Reviewer)
  202. (2012) Editorial Board of Journal of Pharmacy and Pharmaceutical Sciences (Scopus-Cited)-2012 , (Editor)
  203. (2012) Reviewer; Journal of Health Science (October 2012) , (Reviewer)
  204. (2012) Reviewer; American Journal of Medicine and Medical Sciences (October 2012) , (Reviewer)
  205. (2012) Reviewer; International Journal of Diabetes Research (2012) , (Reviewer)
  206. (2012) Reviewer; Journal of Health Sciences (2012) , (Reviewer)
  207. (2012) American Journal of Medicine and Medical Sciences (reviewer; 2012-2014) , (Reviewer)
  208. (2012) Reviewer: DARU J Pharm Sci (ISI)- 2012 , (Reviewer)
  209. (2011) Editorial Board of Journal of Asian Scientific Research , (Editor)
  210. Reviewer for abstracts: 11th Malaysian Pharmaceutical Society-Pharmacy Scientific Conference 2012 (31st Oct-2nd Nov 2012) , (Reviewer)
  211. The Ad-Hoc Committee to evaluate and review the application of Masters of Medical Sciences, University of Malaya for candidate Kanagamalar a / p Subramaniam.
  212. The viva voce and thesis examination for Bachelor of Pharmacy (Hons), The National University of Malaysia for candidate Liew Mei Yao. , (External Examiner)
  213. The Ad-Hoc Committee to evaluate and review the application of Masters of Medical Sciences, University of Malaya for candidate Yvonne Khoo Siew Khoon.
  214. The viva voce and thesis examination for Master of Clinical Pharmacy, The National University of Malaysia for candidate Rozita Mohamad. , (External Examiner)
  215. The Ad-Hoc Committee to evaluate and review the application of Masters of Medical Sciences, University of Malaya for candidate Laith N. Zaki.
  216. The viva voce and thesis examination for Bachelor of Pharmacy (Hons), The National University of Malaysia for candidate Choy Wan Ru. , (External Examiner)
  217. The viva voce and thesis examination for Bachelor of Pharmacy (Hons), The National University of Malaysia for candidate Farrah Idayu Zakaria. , (External Examiner)
  218. The viva voce and thesis examination for Bachelor of Pharmacy (Hons), The National University of Malaysia for candidate Lee Pooi Mun. , (External Examiner)
  219. The viva voce and thesis examination for Master of Clinical Pharmacy, The National University of Malaysia for candidate Neesa Kamarun Begum Mohd Kassim. , (External Examiner)
  220. Reviewer; International Journal of Diabetes Research (February 2013) , (Reviewer)
  221. Reviewer - Brazilian Journal of Pharmaceutical Sciences (ISI-indexed) - September 2017 , (Reviewer)
  222. Reviewer - Clinical Drug Investigation (August 2018) , (Reviewer)
  223. The viva voce and thesis examination for Bachelor of Pharmacy (Hons), The National University of Malaysia for candidate Ng Cheah Phing., (External Examiner)
Contribution to external organisation
  1. (2025) Editorial Board Malaysian Journal of Pharmaceutical Sciences, International, (Expert Advisor)
  2. (2025) Expert Advisor On Clinical Trials, National, (Expert Advisor)
  3. (2025) General Assembly Representative, International, (Expert Advisor)
  4. (2025) External Advisor for Master and Phd, National, (Expert Advisor)
  5. (2025) Task Force Committee - Program Educational Goals, University, (Expert Advisor)
  6. (2025) Member of Drug Control Authority, National, (Expert Advisor)
  7. (2025) Committee Member for Joint Technical Committee, Pharmacy Board Malaysia, National, (Expert Advisor)
  8. (2024) Adjunct Lecturer to Universitas 17 Augustus 1945, International, (Adjunct/Visiting Professors)
  9. (2024) Editorial Board, International, (Expert Advisor)
  10. (2024) Panel of Assessor for Application of Subject Matter Expert and Assessor for Sme Special Assignment, National, (Expert Advisor)
  11. (2022) Ahli Jk Penubuhan UM Health Management Committee, University, (Expert Advisor)
  12. (2022) Research Committee for The Direction of Pharmacy Education in Malaysia, National, (Expert Advisor)
  13. (2022) Head of Organising Committee for Pharmacy Dean Council Award 2021, National, (Expert Advisor)
  14. (2021) Judge MPS-NPC-2021 Poster, Malaysian Pharmacists Society, National
  15. (2021) Committee Members for Development of Pharmacy Expertise via Subject Matter Expert (SME), Ministry of Health Malaysia, National
  16. (2021) Organising Committee - Webinar of Clinical Pharmacy and Clinical Research, Allied Academies, International
  17. (2021) Keynote Speaker - Exploring & Developing Healthcare through Innovative Clinical Pharmacy Methods -Clinical Pharmacy & Pharmacy Research 2021, Allied Academies, International
  18. (2021) Member of ICT Steering Committee, Universiti Malaya, University
  19. (2021) Panel of Evaluators - FRGS Grant, Taylor's University, National
  20. (2021) Panel of Evaluators - FRGS Grant, Universiti Malaya, University
  21. (2021) Member of Asian Council of Science Editors, Asian Council of Science Editors, International
  22. (2021) International Jury Member for International Innovation Awards 2021 (IIA 2021), The International Expo on Innovation and Technology, International
  23. (2020) UM Health Task force (Strategic Initiatives, Governance Model and Processes), UM Health, University
  24. (2020) Pharmacy Dean's Council Committees, Pharmacy Dean council, National
  25. (2020) Board Member for Akademi Pengajian Melayu, Universiti Malaya, Universiti Malaya, University
  26. (2020) Editorial Board- Malaysian Journal of Pharmaceutical Sciences, Universiti Sains Malaysia, International
  27. (2020) Reviewer for Swiss National Science Foundation Grant, Swiss National Science Foundation, International
  28. (2020) Invited Speaker for UM Exclusive Webinar Series: Explore the World of Pharmaceutical Wonders with Faculty of Pharmacy, Universiti Malaya, International
  29. (2020) Editorial Board - African Journal of Pharmaceutical Sciences, Svedberg Open, International
  30. (2020) Speaker for Health Executive Management Programme, University Malaya Medical Centre, National
  31. (2020) Facilitator for Impact Planning Development Workshop - IIRG Cycle 3/2020, Universiti Malaya, University
  32. (2020) Panel of Auditors for Postgraduate Programme Accreditation, The National University of Malaysia, National
  33. (2020) Committee Member for Evaluation of Research Funds, Ministry of Higher Education, National
  34. (2020) Working Committee for the Consortium of Malaysian Teaching Hospital (KHUAM) for Research Cluster, Ministry of Higher Education, National
  35. (2020) Panel of Assessors - COVID-19 Special Grants, Ministry of Higher Education, National
  36. (2020) Permanent Member of Drug Control Authority (DCA), Ministry of Health Malaysia, National
  37. (2020) Panel of Promotion Committee , The National University of Malaysia, National
  38. (2020) Investigator Pool, University of Malaya
  39. (2020) Invited Speaker for USM Pharmacy Webinar: Masking Obstacles of Scientist Mothers: Silence Epidemic Within A Pandemic, USM
  40. (2019) Plenary Speaker for Shah Alam Research Day, Shah Alam Hospital, National
  41. (2019) APPOINTMENT AS CHIEF OBJECTIVE FOR PREPARATION OF OUTCOME EVALUATION REPORT FOR EQUIPMENT PROCUREMENT OF SOUTH TOWER UNIVERSITY OF MALAYA MEDICAL CENTRE, UNIVERSITY MALAYA MEDICAL CENTRE, National
  42. (2019) Supervise two students of Master of Regenerative Medicine for 5 weeks Industrial Attachment, University of Malaya, University
  43. (2019) Organizing Good Clinical Practice Workshop - 6 times a year, Clinical Investigation Centre, National
  44. (2019) Invited Speaker for UMMC Strategic Planning (Thrust 2), University Malaya Medical Centre, University
  45. (2019) Invited Speaker for Translational Core Laboratory (TCL) Career Day, University of Malaya, University
  46. (2018) Invited Speaker - Science Cafe August 2018, University of Malaya, University
  47. (2018) Guest Speaker in the Bernama Today TV Program Live Show Channel 502 (Need to Know - Biosimilars) , Bernama TV, National
  48. (2018) Guest Speaker for 'Selamat Pagi Malaysia' Program Live Show TV1 - Biosimilar, Radio Televisyen Malaysia (RTM), National
  49. (2018) Guest Speaker -Bridging the Gap between Laboratories and Market, Innobioventures and MESTECC, International
  50. (2018) Guest Speaker and Panelist at Innovation Forum Kuala Lumpur 2018, University of Malaya, International
  51. (2018) Expert Opinion - Industry Stakeholders on the Master of Medical Science (Regenerative Medicine) Program, University of Malaya, University
  52. (2018) Reviewer for Malaysian Guideline for Phase I Unit Inspection & Accreditation Programme (First Edition), National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia, National
  53. (2018) External Examiner for Postgraduate Degree - Universiti Sains Malaysia, Universiti Sains Malaysia, National
  54. (2018) Supervise six students of Master of Regenerative Medicine for 3 days Industrial Attachment, University of Malaya, University
  55. (2018) Assessor for Postdoctoral Application - Auckland Medical Research Foundation (March 2018), Auckland Medical Research Foundation, International
  56. (2018) Assessor Panel for Subject Matter Expert (SME) and SME Special Assignments (SSA) for Pharmaceutical Services Division, Ministry of Health Malaysia, Ministry of Health Malaysia, National
  57. (2018) Invited Speaker - Innovation Forum: Entrepreneurship In Health Care, University of Malaya
  58. (2018) Invited Speaker -Science Cafe: FOM Shared Research Facility and Services , Faculty of Medicine
  59. (2018) GCP Workshop October 2018, Clinical Investigation Centre (CIC)
  60. (2018) GCP Workshop December 2018, Clinical Investigation Centre (CIC)
  61. (2018) Invited Speaker - Pre-Clinical and Phase I Clinical Trials in the Cell-Based Therapy and Drug Development Workshop, National Orthopaedic Centre of Excellence in Research and Learning (NOCERAL)
  62. (2018) GCP Workshop July 2018, Clinical Investigation Centre (CIC)
  63. (2018) Assessor Panel for Subject Matter Expert (SME) and SME Special Assignments (SSA) for Pharmaceutical Services Division, Ministry of Health Malaysia, Ministry of Health Malaysia
  64. (2018) GCP Course December 2018, Clinical Investigation Centre (CIC)
  65. (2018) GCP workshop March 2018, Clinical Investigation Centre
  66. (2017) Assessor for Postdoctoral Application - Auckland Medical Research Foundation (September 2017), Auckland Medical Research Foundation , International
  67. (2017) Interviewer Panel for Student Intake - Bachelor of Pharmacy (Honours), University of Malaya, National
  68. (2017) Editorial Board Member, Diabetes and Metabolic Research, International
  69. (2017) Search Comittee for Subject Matter Expert (SME) in Pharmacy (Permanent Member), Pharmacy Division, Ministry of Health Malaysia, National
  70. (2016) Editorial Board Member - Universal Journal of Pharmaceutical Research, Global institute of Pharmaceutical Education and Research, Kashipur, U.K., India, International
  71. (2016) Editorial Board Member -Austin Andrology, Austin Publishing Group, International
  72. (2016) Editorial Board Member - Austin Renal Disorders, Austin Publishing Group, International
  73. (2016) Expert Panel for Development of Clinical Pharmacy Specialist in Malaysia, Pharmaceutical Services Division, Ministry of Health Malaysia, National
  74. (2016) Interviewer Panel for New Undergraduate Students Intake; 2016, University of Malaya
  75. (2015) Editorial Board Member, SM Journal of Endocrinology and Metabolism, International
  76. (2015) Exhibitor/Conference delegates for Biopharma Asia Convention 2015 , Terrapin, Singapore
  77. (2015) Interviewer Panel for New Undergraduate Students Intake; 2015 , University of Malaya
  78. (2015) Invited Speaker : 45th MALAYSIAN ORTHOPAEDICASSOCIATION ANNUALSCIENTIFIC MEETING 2015- Orthopaedic Postoperative Pain Management -The Impact Of Pharmacogenomics Of Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Malaysian Orthopaedic Association
  79. (2015) Invited Speaker for Medico-Legal Course - Roles of Clinical Investigation Centre and Phases of Clinical Trials , Exco of Teaching Hospital and Legal Advisory Council of Malaysian Public Universities
  80. (2015) Panel of Award Judges : 45th MALAYSIAN ORTHOPAEDIC ASSOCIATION ANNUAL SCIENTIFIC MEETING 2015, Malaysian Orthopaedic Association
  81. (2015) Poster Judge - Faculty of Medicine Research Week 2015 (11-15 May 2015), Faculty of Medicine, University of Malaya
  82. (2014) Editorial Board Member, Journal of Disease Markers, Austin Publishing Group USA, International
  83. (2014) Editorial Board - IORP Journal of Dentistry Medicine Pharmacy, IORP Journals, International
  84. (2014) JUDGE for the 44th MALAYSIAN ORTHOPAEDIC ASSOCIATION ANNUAL SCIENTIFIC MEETING 2014 MAHMOOD MERICAN AWARD, MALAYSIAN ORTHOPAEDIC ASSOCIATION
  85. (2014) Judge - Scientific Poster Research Competition - 13th IPSF Asia Pacific Pharmaceutical Symposium (APPS) 2014, Malaysian Pharmacy Students Association (MyPSA) and International Pharmaceutical Students Federation (IPSF)
  86. (2014) Curriculum Restructuring Panel Member for Postgraduate Degree for Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Faculty of Pharmacy, Universiti Kebangsaan Malaysia
  87. (2014) Interviewer Panel for New Undergraduate Students Intake; 11 Apr 14; 23-29 May 2014 , University of Malaya
  88. (2014) Invited Speaker : 44th MALAYSIAN ORTHOPAEDIC ASSOCIATION ANNUAL SCIENTIFIC MEETING 2014 - Personalized Medicine --- Potential Applications to Orthopedic Practice, Malaysian Orthopaedic Association
  89. (2014) Judge - Taylor's University Pharmacy Student Quiz - Final round , Taylor's University
  90. (2014) Exhibitor/Conference delegates for Biopharma Asia Convention 2014, Terrapin Pte Ltd (Singapore)
  91. (2014) Invited Speaker for Program Balanced Living in A Serene Campus (BLISS): Common Supplements for Women and Children, Student Empowerment Research Unit (SERU, University of Malaya
  92. (2013) Editorial Board, Journal of Pharmaceutical and Biomedical Research, International
  93. (2013) Editorial Board Members, Journal of Endocrinology and Diabetes Mellitus, International
  94. (2013) Advisory Board, OA Endocrinology (OA Publishing London), International
  95. (2013) Judge (Oral Presentations); 2nd Pharmaceutical Research Conference for Pharmacy Students & Young Graduates: 11-12th May 2013., CUCMS
  96. (2013) 'Conducting Clinical Trials in University of Malaya' for Research Week in commemoration of 50th Anniversary Celebration of Faculty of Medicine, University Malaya, Faculty of Medicine, University of Malaya
  97. (2013) Interviewer Panel for New Undergraduate Students Intake; 20-23 May 13, University of Malaya
  98. (2013) Training Module for Assistant/Research Assistant (RA): Module 3: Research Ethics used in FOM), Research Management Centre, Faculty of Medicine, University of Malaya
  99. (2013) Interviewer Panel for New Undergraduate Students Intake; 13 Apr 13, University of Malaya
  100. (2012) Reviewer, Journal of Health Science, International
  101. (2012) Reviewer, International Journal of Diabetes Research, International
  102. (2012) Reviewer, Clinical Practice, International
  103. (2012) Reviewer, American Journal of Medicine & Medical Sciences, International
  104. (2012) Editorial Board, International Journal of Pharmacy and Pharmaceutical Sciences (SCOPUS-Cited), International
  105. (2012) Editorial Board, Mintage Journal of Pharmaceutical and Medical Sciences, International
  106. (2012) Judge for oral and poster presentations at the 1st Pharmaceutical Research Conference for Pharmacy Students & Young Graduates 2012, CUCMS
  107. (2012) A night with Professors & Alumni, Orientation of New Students for Academic Year 2012/13., Faculty of Medicine, University of Malaya
  108. (2011) Editorial Board, Journal of Asian Scientific Research, International
Contribution to event
  1. (2024) Moderator, National, (Panelist/Moderator)
  2. (2022) Organizing Committee, International, (Event Organiser)
  3. (2022) Keynote Speaker, International, (Panelist/Moderator)
  4. (2022) Speaker for International Conference On Advances of Pharmaceutical and Health Sciences, International, (Panelist/Moderator)

SUPERVISION

Postgraduate Student
PhD/ Doctoral
  1. (2024) Assessing the Application and Impact of Therapeutic Drug Monitoring on Clinical Outcomes in Sudan: A study on Tacrolimus, Cyclosporine and High Dose Methotrexate., AMNA AHMED ABBAS AHMED
  2. (2024) Predictors of Sexual Functions and Perceived Effectiveness of Vaginal Treatments among Perimenopausal and Postmenopausal Women with the Genitourinary Syndrome of Menopause., MOHAMMED HASSANEIN
  3. (2024) Development of a Framework for Drug Procurement, Utilization, and Guideline Adherence in Type 2 Diabetes Management: Insights from the Malaysian Armed Forces Healthcare Services, MANVIKRAM GILL
  4. (2024) Investigation of Personalised Learning Framework in Higher Education for Health Sciences Coursesā€™, MAJID ALI
  5. (2024) Investigating the effect of SGLT-2 Inhibitors on Epicardial Adipose Tissue in Type 2 Diabetic Patients with Coronary Artery Disease, WAN AHMAD SYAZANI BIN MOHAMED
  6. (2024) Clinical and Genetics factors Associated with Mycophenolic Acid Treatment in Patients with Lupus Nephritis in Malaysia, ESRA NASRALDIN KHALIL SHARAFALDIN
  7. (2024) Clinical Assessment of Supplement Intake Trends and Influencing Factors in the UAE and Healthcare System Digital Determinants, SABRINA AIT GACEM
  8. (2024) Investigation of Immunotherapy Utilisation and Its Potential for Relapse and Refractory Acute Lymphocytic Leaukemia in Malaysian Adults., MEI PIN NGU
  9. (2024) Perception, Adherence and Clinical outcomes of Care Aide app usage in chronic diseases, RAJAT RANA
  10. (2024) A Comprehensive Evaluation of Flash Continuous Glucose Monitoring (CGM) in Clinical Practice: Efficacy, Patient Satisfaction, Cost-Effectiveness, and Implementation Challenges., ABUZAR WATAN PAL
  11. (2023) Perception, Adherence, Clinical, Economical and Health-Related Quality of Life Outcomes of CareAideĀ® App usage in Chronic Diseases, Priyanka Sandeep Mangle
  12. (2023) OPEN, RANDOMIZED, PARALLEL GROUP STUDY TO ASSESS EFFICACY, SAFETY, AND TOLERABILITY OF REPEAT DOSES OF VAGINAL HYALURONIC GEL IN PRE- AND POST- MENOPAUSAL FEMALE, JACQUELINE MARK KAR KEI
  13. (2022) Effect of SLC2A2 and SLC22A1 gene Polymorphisms on Glycemic Control and Metformin intolerance in Type 2 Diabetes Patients at St Paul s Hospital and Zewuditu Memorial Hospital, Addis Ababa, Ethiopia, Abraham Degaga Abdi (Addis Ababa University, Ethopia)
  14. (2022) A RETROSPECTIVE COHORT STUDY TO EVALUATE THE RISK OF ADVERSE MATEROMES IN EARLY PREGNANCY ASSOCIATED WITH VITAMIN D DEFICIENCY, Anina Qureshi
  15. (2022) Pharmacometabolomic Study of Metformin Tablets and Andrographis Paniculata Capsules Using Pharmacokinetic and Dose-Dependent Approach, TEE KHIM BOON
  16. (2022) CLINICAL AND GENETIC MARKERS ASSOCIATED WITH ERYTHROPOIETIN DEFICIENCY ANAEMIA AND ERYTHROPOETIN STIMULATING AGENT TREATMENT RESPONSE IN PRE-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS, NAVA YUGAVATHY A/P SELVARAJA
  17. (2021) CLINICAL AND GENETIC ASSOCIATIONS OF INSULIN RESISTANCE AND SEVERITY OF CORONARY ARTERY DISEASE (CAD) IN TYPE 2 DIABETES (T2D) PATIENTS., SANGEETHA A/P PERUMALSAMY
  18. (2021) ASSESSMENT OF SHARED DECISION MAKING IN THE PHARMACOLOGICAL MANAGEMENT OF MAJOR DEPRESSIVE DISORDER: TOWARDS A PATIENT, PHYSICIAN AND PHARMACIST CENTRED APPROACH, AYA AHMED ABOUSHEISHAA MOHAMED KHALIL
  19. (2020) Treatment Pattern and Outcome of Lupus Nephritis in Malaysia, Esra Nasraldin Khalil Sharafaldin
  20. (2019) ENABLING PATIENT-CENTRED CARE AND ENGAGEMENT THROUGH SHARED DECISION MAKING IN ANTIDEPRESSANT USE AMONG PATIENTS WITH MAJOR DEPRESSIVE DISORDER., SYAHRIR BIN ZAINI
  21. (2019) CLINICAL AND GENETIC PREDICTORS OF SECONDARY SULPHONYLUREA FAILURE AND SULPHONYLUREA-INDUCED HYPOGLYCEMIA IN MALAYSIAN TYPE 2 DIABETES PATIENTS: A PROSPECTIVE MULTICENTRE STUDY (SUCLINGEN), NAVIN KUMAR A/L LOGANADAN
  22. (2018) Phase 1 Clinical Trial: Bioavailability and Pharmacokinetics Study: Integration of Pharmacometabolomics into Pharmacokinetics and Pharmacodynamics for Orthosiphonaristatus (MisaiKucing) and Glibenclamide in Healthy Volunteers, Tee Khim Boon
  23. (2017) Clinical and Genetic Markers of EPO Deficiency Anemia in CKD Patients, Nava Yugavathy
  24. (2017) Association of Effect of Using Antipsychotic Medications and Glycemic Control Among Malaysian Type I & II Diabetes Mellitus Patients, Aya Ahmad Abousheishae
  25. (2016) Association of Genetic Polymorphisms of Dipeptidyl Peptidase - 4 with Type 2 Diabetes Mellitus in Malaysian Subjects, RADWAN HAMOUD ALI AHMED
  26. (2016) CLINICAL AND GENETIC ASSOCIATIONS OF DIPEPTIDYL PEPTIDASE-INHIBITOR TREATMENT RESPONSE IN TYPE 2 DIABETES., JAZLINA LIZA BT. JAMALUDDIN
  27. (2015) Potential Clinical and Genetic Predictors of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients With Coronary Artery Disease (CAD), Sangeetha Perumalsamy
  28. (2015) Assessment of Prescribing Pattern of Statins in Malaysian Type 2 Diabetes Patients: Pre vs Post Educational Intervention, Mohamed Hasan Abdelaziz Elnaem (M0100106)
  29. (2014) Cost Effectiveness of a Pharmacist Telemonitoring Programme for Antidepressant Use, SYAHRIR BIN ZAINI
  30. (2013) Clinical and Genetic Predictors of Sulphonylureas Among Malaysian Type 2 Diabetes Patients, Navin Kumar Loganadan
  31. (2013) Association of Genetic Polymorphisms of Dipeptidyl Peptidase-4 with Type 2 Diabetes and Metabolic Syndrome In Malaysian Population (passed with distinction), Radwan Hamoud Ali
  32. (2012) Metabolic Profiling of Urine and Blood Samples from Healthy Volunteers, Impaired Fasting Glucose and Type 2 Diabetic Patients Using Ultra Performance Liquid Chromatography (LC)-QTRAP MS (passed with distinction), Mohamad Hafizi Abu Bakar (M0100105)
  33. (2012) Clinical and Genetic Associations of DPPIV Treatment Response in Type 2 Diabetes Patients, Jazlina Liza Dato' Jamaluddin
Master
  1. (2024) Elucidation of the mechanism of mild cognitive impairment and aging using metabolomics approach, Binjin Zhao
  2. (2024) Associations between Glycemic Control, Antihyperglycemic Agents and Antibiotic Therapy with the Severity of Diabetic Foot Ulcers Among Type 2 Diabetes Patients., IDRIS AJIBOLA OMOTOSHO
  3. (2024) HEALTH INTERVENTION PROGRAMME AND PUBLIC PERCEPTION IN THE MANAGEMENT OF NON-COMMUNICABLE DISEASES (NCDS) IN COMMUNITY PHARMACY IN MALAYSIA, TAN CHIN HAO
  4. (2023) Evaluation of Clinical Outcomes of Diabetes Patients with Hypertension Vaccinated with Sinovac Vaccine, Sofia Ngarso (Universitas Indonesia)
  5. (2023) Development of Universiti Malaya Medical Centre Paediatric Dose (UMMC-PediDos) Database Research Proposal, XIN JIANG
  6. (2023) Effectiveness of Covid-19 Vaccines Towards Different SARS-COV-2 Variants and Perception of Malaysians Towards Booster Dose, SURESH A/L RAJAKUMAR
  7. (2021) Association Between the Antihyperglycemic Agents, Glycemic Control and Antibiotic Therapy with the Severity of Diabetic Foot Ulcers Among Type 2 Diabetes, Idris Ajibola Omotosho
  8. (2021) A STUDY ON THE EFFECTS OF ANTIHYPERGLYCAEMIC DRUGS AND GLYCAEMIC CONTROL ON LEFT VENTRICULAR EJECTION FRACTION IN HEART FAILURE PATIENTS WITH TYPE 2 DIABETES, LIN SHU NING
  9. (2019) ASSOCIATION OF ANTIHYPERGLYCEMIC REGIMENS WITH GLYCAEMIC CONTROL AND CARDIOVASCULAR OUTCOMES IN HEART FAILURE PATIENTS, LIN SHU NING
  10. (2018) Adherence to prophylaxis regimen and bleeding disorder in haemophilia, FADZLIN MOHD MOKHTAR
  11. (2018) ASSOCIATIONS OF GENETIC POLYMORPHISMS AND CLINICAL PARAMETERS WITH POOR GLYCAEMIC CONTROL IN OVERWEIGHT AND OBESE TYPE 2 DIABETES MELLITUS PATIENTS., NOR BAHIRAH BINTI KASIM
  12. (2017) ASSOCIATION OF SIMVASTATIN USE WITH GLYCEMIC CONTROL IN TYPE 2 DIABETES PATIENTS RECEIVING ORAL ANTIHYPERGLYCEMIC THERAPY AND IN NON-DIABETIC SUBJECTS, NOR RAZIDA BINTI RAZALI
  13. (2016) IN VITRO APOPTOSIS INDUCTION AND INHIBITION OF NF-kB SIGNALIING PATHWAY BY BISEUGENOL B IN PC3 HUMAN PROSTATIC CANCER CELSS, MARYAM ABBASPOUR BABAEI
  14. (2016) TOTAL TESTOSTERONE AND ASYMMETRIC DIMETHYLARGINIINE: ASSOCIATION OF DEMOGRAPHIC, CLINICAL AND LIFESTYLE FACTORS WITH THE SEVERITY OF ERECTILE DYSFUNCTION, RAY MOND MARK A/L JOSEPH
  15. (2014) Glycemic control in Type 2 Diabetes Mellitus among Simvastatin User, Nor Razida binti Razali
  16. (2014) Genetic Markers in Uncontrolled Type 2 Diabetes Mellitus Patients with Obesity, Nur Bahirah Kasim
  17. (2013) Natural Compound 2,2'-Oxybis (4-allyl-1-methoxybenzene), biseugenol B, from Litsea Costalis, Exhibits Apoptogenic Properties in human prostate cancer cell (PC3) via Induction of intrinsic, extrinsic apoptosis pathways and inhibition of NF- B signaling pathway, an in-vitro study, MARYAM ABBASPOUR BABAEI
  18. (2013) Association of Biomarkers with Comorbidities, Drug Treatments and Psychological Factors in Patients with Erectile Dysfunction, Raymond Mark Joseph
Under Graduate Students
  1. (2019) GLYCEMIC CONTROL AND ANTIDIABETIC DRUGS IN TYPE 2 DIABETES PATIENTS WITH CHRONIC THIAZIDES DIURETIC THERAPY IN UMMC
  2. (2019) CLINICAL CHARACTERISTICS AND MANAGEMENT OF THYROID DISORDERS IN UMMC
  3. (2019) ASSOCIATION OF ATORVASTATIN WITH LIPID PARAMETER AND GLYCEMIC CONTROL IN TYPE 2 DIABETES MELLITUS PATIENTS IN UMMC
  4. (2019) ANTIHYPERTENSIVES UTILIZATION IN TYPE 2 DIABETES PATIENTS IN UMMC
  5. (2018) Students' Readiness For Interprofessional Learning (IPL) in Cyberjaya University College of Medical Science (CUCMS) (000000394)
  6. (2018) Incidence of Depression among Undergraduate Pharmacy Students in Malaysia (000000394)
  7. (2018) Glycemic Control and Antidiabetic Drugs in Type 2 Diabetes Patients with Overweight and Obesity
  8. (2018) Glycemic Control and Antidiabetic Drugs in Type 2 Diabetes Patients with Chronic Glucocorticoid Therapy
  9. (2018) Drug Related Problems in Type 2 Diabetes Patients with Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State
  10. (2018) Assessment of Factors Associated with Attainment of Glycemic Control in Type 2 Diabetes Patients
  11. (2017) Glycemic Control and Antidiabetic Drugs in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
  12. (2017) Drug Related Problems in Patient with Rheumatoid Arthritis
  13. (2017) Drug Related Problems in Patient with Chronic Kidney Disease
  14. (2017) Association of Clinical Factors, Anemia and Treatment Response in Pre-Dialysis Chronic Kidney Disease Patients
  15. (2016) Medication errors analysis in University Malaya Medical Centre (UMMC) Inpatient Pharmacy
  16. (2016) Insulin treatment in type 2 diabetes mellitus patients with coronary artery disease
  17. (2016) Factors Associated with Erythropoietin Stimulating Agents (ESAs) treatment response in Chronic Kidney Disease
  18. (2015) Survey on the use of complementary alternative medicines (CAM) in type 2 diabetes patients
  19. (2015) Survey on self-monitoring of blood glucose (SMBG) and sick day management in patients with type 2 diabetes
  20. (2015) Glycaemic control and antidiabetic drugs in type 2 diabetes mellitus patients with diabetic foot complications
  21. (2015) Drugs related problems in type 2 diabetes patients with acute hyperglycemia
  22. (2015) Drug related problems in type 2 diabetes patients with cardiovascular disease
  23. (2014) Utilisation of sliding scale insulin in type 2 diabetes mellitus patients during severe/acute hyperglycemia
  24. (2014) Survey on the use of complementary alternative medicines (CAM) in type 2 diabetes patients
  25. (2014) Drugs related problems in type 2 diabetes patients with acute hyperglycemia
  26. (2014) Drug related problems in type 2 diabetes patients with cardiovascular disease
  27. (2014) Drug-related problems in patients with erectile dysfunction and multiple comorbidities
  28. (2014) Comparison of efficacy and safety of a fixed versus variable dose regimen of intravenous insulin in type 2 diabetes patients
  29. (2014) Comparison of efficacy and adverse effects of human insulin and analogue insulin among diabetes mellitus patients with multiple comorbidities
  30. (2014) Cardiovascular events and glycemic control in type 2 diabetes mellitus patients treated with statins
  31. (2014) A survey of diabetes self management in type 2 diabetes management glycemic control
  32. (2014) A study on glycaemic control and antidiabetic drugs in type 2 diabetes mellitus patients with diabetic foot complications
  33. (2013) Glycaemic control and antidiabetic drugs in type 2 diabetes mellitus patients with renal complications
  34. (2013) Glycaemic control and antidiabetic drugs in type 2 diabetes mellitus patients with diabetic retinopathy
  35. (2013) Glycaemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications.
  36. (2013) A survey on psychological factors, patients knowledge and drug treatments amongst patients with erectile dysfunction
  37. (2012) Utilisation of DPP4-inhibitor in type 2 diabetes mellitus patients
  38. (2012) Management of severe/acute hyperglycaemia in hospitalised type 2 diabetes patients
  39. (2012) Drug-related problems in patients with benign prostatic hyperplasia
  40. (2012) Characteristics and management of patients with erectile dysfunction
  41. (2012) A retrospective study on hypoglycemia episodes in hospitalised type 2 diabetes mellitus patients
  42. (2011) Drugs-related problems in hospitalized type 2 diabetes patients
  43. (2011) Drug-related problems in type 2 diabetes patients with hypertension
  44. (2011) Drug-related problems in type 2 diabetes patients with dyslipidemia
  45. (2011) A study on response to diabetes medications in type 2 diabetes mellitus patients
  46. (2006) Utilization of sliding scale insulin in an endocrine ward
  47. (2006) Utilisation of sulphonylureas amongst type 2 diabetic
  48. (2006) Utilisation of antiplatelet among diabetes patients
  49. (2006) A survey of SMBG amongst type II diabetics
  50. (2005) Complementary and Alternative Medicine Use Among Adults Diabetes with diabetes
  51. (2005) A study on The Use Of Sliding Scale Insulin In An Endocrine Ward
  52. (2005) A study of Diabetic Ketoacidosis (DKA) in adult patients with diabetes mellitus
  53. (2005) A study of Antihypertensives Use in Diabetic Hypertensive Patients In a Teaching Hospital

TEACHING

Doctor Of Philosophy
  1. (2024) OVA8001 - Research Methodology
  2. (2023) OVA8001 - Research Methodology
  3. (2022) OVA8001 - Research Methodology
Master
  1. (2024) OMX7001 - Research Methodology
  2. (2023) OMX7001 - Research Methodology
  3. (2022) OMX7001 - Research Methodology
  4. (2021) OMX7001 - Research Methodology
  5. (2021) OMX7001 - Research Methodology
  6. (2021) OVA8001 - Research Methodology
  7. (2019) MVX8001 - Research Methodology
  8. (2019) MVX8001 - Research Methodology
  9. (2019) MXGZ6101 - Research Methodology for Research Mode Programmes
  10. (2019) MXGZ6101 - Research Methodology for Research Mode Programmes
  11. (2018) MXGZ6101 - Research Methodology for Research Mode Programmes
  12. (2017) MXGZ6101 - Research Methodology for Research Mode Programmes
  13. (2016) MXGZ6101 - Research Methodology for Research Mode Programmes
  14. (2016) MXGZ6101 - Research Methodology for Research Mode Programmes
  15. (2015) MXGZ6101 - Research Methodology for Research Mode Programmes
  16. (2014) MXGZ6101 - Research Methodology for Research Mode Programmes
Bachelor
  1. (2024) OIA3005 - Pharmacotherapy for Endocrine Disorders
  2. (2023) OIA3005 - Pharmacotherapy for Endocrine Disorders
  3. (2022) OIA3005 - Pharmacotherapy for Endocrine Disorders
  4. (2021) OIA3005 - Pharmacotherapy for Endocrine Disorders
  5. (2021) OIA3005 - Pharmacotherapy for Endocrine Disorders
  6. (2020) OIA4005 - Clinical Clerkship
  7. (2020) OIA4008 - Clinical Clerkship Ii
  8. (2019) MIB3021 - Pharmaceutical Biotechnology
  9. (2019) MIC4006 - Laboratory Management and Quality Control
  10. (2019) OIA3005 - Pharmacotherapy for Endocrine Disorders
  11. (2018) MIB4010 - Pharmacotherapy for Special Populations
  12. (2018) MWEF3108 - Pharmaceutical Biotechnology
  13. (2017) MIB3005 - Pharmacotherapy for Endocrine Disorders
  14. (2017) MWEF4103 - Clinical Pharmacy and Pharmacotherapy Ii
  15. (2016) MWEF3108 - Pharmaceutical Biotechnology
  16. (2016) MWEF4105 - Clinical Clerkship I
  17. (2016) MWEF4111 - Clinical Clerkship Ii
  18. (2015) MBEB4104 - Quality Control and Laboratory Management
  19. (2014) MWEF3102 - Introduction to Clinical Pharmacy
  20. (2014) MWEF3108 - Pharmaceutical Biotechnology
  21. (2014) MWEF4105 - Clinical Clerkship I
  22. (2013) MWEF3102 - Introduction to Clinical Pharmacy
  23. (2013) MWEF4103 - Clinical Pharmacy and Pharmacotherapy Ii
  24. (2013) MWEF4103 - Clinical Pharmacy and Pharmacotherapy Ii
  25. (2012) MWEF3102 - Introduction to Clinical Pharmacy
  26. (2012) MWEF3107 - Clinical Pharmacy and Pharmacotherapy I
  27. (2012) MWEF3108 - Pharmaceutical Biotechnology
  28. (2012) MWEF4103 - Clinical Pharmacy and Pharmacotherapy Ii
  29. (2012) MWEF4105 - Clinical Clerkship I
  30. (2012) MWEF4108 - Intergrated Pharmacotherapy
  31. (2012) MWEF4108 - Intergrated Pharmacotherapy
  32. (2011) MWEF3102 - Introduction to Clinical Pharmacy
  33. (2011) MWEF4103 - Clinical Pharmacy and Pharmacotherapy Ii
  34. (2011) MWEF4104 - Hospital Pharmacy Services
  35. (2007) MWEF1132 - Endocrine, Gastrointestinal System & Therapy
  36. (2007) MWEF2163 - Clinical Pharmacy & Therapeutics I
  37. (2007) MWEF2348 - Nutritional Supplements
  38. (2007) MWEF3161 - Clinical Pharmacy and Therapeutics Iv
  39. (2007) MWEF3168 - Clinical Pharmacy and Therapeutics Ii
  40. (2007) MWEF3169 - Clinical Pharmacy & Therapeutics III
  41. (2006) MWEF1132 - Endocrine, Gastrointestinal System & Therapy
  42. (2006) MWEF2163 - Clinical Pharmacy & Therapeutics I
  43. (2006) MWEF2348 - Nutritional Supplements
  44. (2006) MWEF3161 - Clinical Pharmacy and Therapeutics Iv
  45. (2006) MWEF3168 - Clinical Pharmacy and Therapeutics Ii
  46. (2006) MWEF3169 - Clinical Pharmacy & Therapeutics III
  47. (2005) MWEF1132 - Endocrine, Gastrointestinal System & Therapy
  48. (2005) MWEF2138 - Respiratory Blood System & Therapy
  49. (2005) MWEF2163 - Clinical Pharmacy & Therapeutics I
  50. (2005) MWEF3161 - Clinical Pharmacy and Therapeutics Iv
  51. (2005) MWEF3168 - Clinical Pharmacy and Therapeutics Ii
  52. (2005) MWEF3169 - Clinical Pharmacy & Therapeutics III
  53. (2004) MWEF2146 - Pharmacy Practice Ii
  54. (2004) MWEF2163 - Clinical Pharmacy & Therapeutics I
  55. (2004) MWEF3169 - Clinical Pharmacy & Therapeutics III

PATENT/ IPR

  • Logo for PEARL (values for Faculty of Pharmacy)
    TRADEMARK
  • The protocol (Data collection, management and statistical analyses)
    TRADEMARK
  • A Method for Producing Directly Compressible Sago Starch
    PATENT
  • A METHOD FOR PRODUCING DIRECTLY COMPRESSIBLE SAGO STARCH
    Industrial Design (National)

SOCIAL RESPONSIBILITY ACTIVITIES

  • Ipsf Students Exchange Program 2017 - Supervise Two(2) Pharmacy International Students for a Research Project, (17 Jul 2017 - 28 Jul 2017)
  • Organizing Committee (coordinator for Theme 2: Pill to Heal)- Faculty of Medicine Research Week (fomrw) 2015, (11 May 2015 - 15 May 2015)
  • Organizing Committee (sponsorship)- Faculty of Medicine Research Week (fomrw) 2015, (11 May 2015 - 15 May 2015)
  • Organizing Committee (treasurer)- Faculty of Medicine Research Week (fomrw) 2015, (11 May 2015 - 15 May 2015)
  • Organizing Committee (sponsorship) of The Golden Helix Symposium 2015., (11 Mar 2015 - 13 Mar 2015)
  • Organizing Committee of The UM-lmif Short Course On Translational Medicine, (08 Dec 2014 - 12 Dec 2014)
  • Organising Committee: Good Clinical Practice (gcp) Workshop, (08 Apr 2014 - 10 Apr 2014)
  • Organiser (registration): Opening Ceremony of Research Week in Commemoration of 50th Anniversary Celebration Faculty of Medicine, University of Malaya, (21 Jan 2013 - 23 Jan 2013)
  • 11th Mps Pharmacy Scientific Conference 2012 (mps-psc 2012) [head of Registration Committee], (30 Oct 2012 - 02 Nov 2012)
  • 11th Mps Pharmacy Scientific Conference 2012 (mps-psc 2012) [secretary Ii], (30 Oct 2012 - 02 Nov 2012)
  • Founder of Pharmacy Alumni Society, University of Malaya (phaum), (09 Aug 2012)
  • Founder of a New Student Award for UM Pharmacy Students (icon of UM's Pharmacy Students 2012), (17 Feb 2012)
  • Mps Scientific Conference 2006 (head of Registration Committee), (01 Sep 2006 - 03 Sep 2006)
  • Pharmacy Society, University of Malaya (founder for The Notice Board & Webpage), (30 Jun 2006)

COURSE ATTENDED

Internal/ External Course
  1. INTEGRATIVE GENDER-SENSITIVE TRAINING FOR MEDICAL & HEALTH TEACHING WORKSHOP, FAKULTI PERUBATAN, UM (22 Nov 2005 - 22 Nov 2005)
  2. OBSTETRICS & GYNECOLOGY PHARMACY CONFERENCE, HOTEL GOLDCOURSE, KLANG, SELANGOR (12 Aug 2005 - 14 Aug 2005)
  3. 6TH PHARMACY SCIENTIFIC CONFERENCE, HOTEL CROWN PRINCESS, KUALA LUMPUR (01 Sep 2006 - 04 Sep 2006)
  4. KURSUS INDUKSI, HOTEL SINGGAHSANA (12 Jun 2006 - 26 Jun 2006)
  5. 10TH CONTINUING PROFESSIONAL DEVELOPMENT SERIES: DIABETES ASIA 2011 CONFERENCE, SUNWAY RESORT HOTEL & SPA CONVENTION (06 Oct 2011 - 09 Oct 2011)
  6. WORKSHOP ON PATENT DRAFTING, RUMAH UNIVERSITI, UM (29 May 2007 - 31 May 2007)
  7. BIOPHARMA ASIA CONVENTION 2015 - NAVIGATING THE FUTURE OF ASIA BIOPHARMACEUTICAL INDUSTRY, SUNTEC SINGAPORE CONVENTION & EXHIBITION CENTRE (22 Mar 2015 - 26 Mar 2015)
  8. E-LEARNING INNOVATION ASPIRATION, MICROSOFT TEAMS (31 Mar 2023 - 31 Mar 2023)
  9. BENGKEL KEPIMPINAN QUANTUM LEADERSHIP PROGRAM FOR HEALTHCARE PROFESSIONALS, GRAND BLUE WAVE HOTEL, SHAH ALAM (12 May 2017 - 14 May 2017)
  10. BENGKEL PENGURUSAN RISIKO, CORUS PARADISE RESORT, PORT DICKSON, N. SEMBILAN (06 Feb 2017 - 08 Feb 2017)
  11. BENGKEL POST MORTEM: ONLINE TEACHING & LEARNING AND INTERNATIONALISATION (25 OGOS 2020), BENGKEL POST MORTEM: ONLINE TEACHING & LEARNING AND INTERNATIONALISATION (25 Aug 2020 - 25 Aug 2020)
  12. KURSUS SEMAKAN PENERBITAN DALAM WOS DAN SCOPUS, SECARA DALAM TALIAN MELALUI APLIKASI GOOGLE MEET (01 Jul 2021 - 01 Jul 2021)
  13. WORKSHOP ON DESIGNING AND DEVELOPING ASSESSMENT METHODS AND QUESTIONS, PUTRAJAYA MARRIOTT HOTEL (13 Oct 2022 - 13 Oct 2022)
  14. BENGKEL LATIHAN PROBLEM-BASED LEARNING (PBL), FAKULTI PERUBATAN, UM (16 Jun 2005 - 23 Jun 2005)
  15. CLINICAL TRIAL SOURCE DOCUMENTATION AND COMMON GCP DEFICIENCIES, UMMC (05 Mar 2015 - 05 Mar 2015)
  16. KURSUS PENGAJARAN BERKESAN/PENGURUSAN KURIKULUM, HOTEL SINGGAHSANA (26 Apr 2005 - 27 Apr 2005)
  17. WORKSHP : SPECTRUM BASIC, MAKMAL KOMPUTER FAKULTI PERUBATAN (11 Feb 2015 - 11 Feb 2015)
  18. ACCP'S BPS TUTORIAL, HOTEL ISTANA KL (26 Mar 2012 - 28 Mar 2012)
  19. BENGKEL KEPIMPINAN-A BREAKTHROUGH IN QUALITY MINDSET, HOTEL PULLMAN KUALA LUMPUR BANGSAR (15 Dec 2014 - 15 Dec 2014)
  20. TRADITIONAL AND COMPLEMENTARY MEDICINE (TCM) STAKEHOLDERS' WORKSHOP, HOTEL CRYSTAL CROWN, PETALING JAYA, SELANGOR (21 Jun 2007 - 21 Jun 2007)
  21. A BREAKTHROUGH IN QUALITY MINDSET, PULLMAN HOTEL, BANGSAR (15 Dec 2014 - 15 Dec 2014)
  22. CONTINUING PROFESSIONAL DEVELOPMENT: 5TH DIABETES UPDATE, SUNWAY PYRAMID CONVENTION CENTRE, SELANGOR (09 Nov 2006 - 12 Nov 2006)
  23. BENGKEL KEPIMPINAN - A BREAKTHROU GH IN QUALITY MIND-SET , PULLMAN HOTEL, BANGSAR (15 Dec 2014 - 15 Dec 2014)
  24. KURSUS INDUKSI, ARAS 1, BANGUNAN PEPERIKSAAN (29 Jun 2006 - 29 Jun 2006)
  25. BENGKEL KAJIAN SEMULA KURIKULUM SARJANA MUDA FARMASI, HOTEL HATTEN MELAKA (05 Apr 2013 - 07 Apr 2013)
  26. KURSUS INDUKSI, PUSAT PENGAJIAN LUAR ULU GOMBAK UM (09 Jun 2006 - 11 Jun 2006)
  27. BENGKEL PERSEDIAAN PENEMUDUGA KEMASUKAN PELAJAR 2013/14, DEWAN 3, BANGUNAN PEPERIKSAAN UM (25 Mar 2013 - 25 Apr 2013)
  28. CONTINUING PROFESSIONAL DEVELOPMENT: 4TH PRACTICAL DIABETES UPDATES, SUNWAY PYRAMID CONVENTION CENTRE, SELANGOR (01 Sep 2005 - 04 Sep 2005)
  29. 1ST ASIA PACIFIC CLINICAL EPIDEMIOLOGY AND EVIDENCE BASED MEDICINE CONFERENCE, SUNWAY PUTRA HOTEL (FORMERLY KNOWN AS THE LEGEND HOTEL & APARTMENTS), KUALA LUMPUR (06 Jul 2012 - 08 Jul 2012)
  30. RESEARCH METHODS INTRODUCTORY COURSE, FAKULTI PERUBATAN, UM (26 Jul 2005 - 28 Jul 2005)
  31. GENE EXPRESSION USING RT-PCR/QPCR, IMMB, UITM SUNGAI BULOH SELANGOR (13 Jun 2012 - 13 Jun 2012)
  32. KURSUS PENGENALAN KEPADA SPSS, MAKMAL MIKRO 1 (25 May 2005 - 26 May 2005)
  33. PROTEOMICS-PROTEIN EXPRESSION, MAKMAL BIOTEKNOLOGY UM (16 May 2012 - 17 May 2012)
  34. GOOD CLINICAL PRACTICE WORKSHOP, CIC, UMMC (21 Jan 2005 - 29 Jan 2005)
  35. INTERNATIONAL CONGRESS OF PATHOLOGY AND LABORATORY MEDICINE, WORLD TRADE CENTRE, KUALA LUMPUR (21 Sep 2023 - 21 Sep 2023)